• Author Index
• Abstract Index
• Search
• Journal Homepage
• ISTH Homepage
• Online Journal
• Privacy Policy
• 2003
• 2005
• 2007
• 2009

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

P
Paar D.	-	EVALUATION OF VENOUS THROMBOEMBOLIC RISK PROFILES IN ACUTELY ILL MEDICAL PATIENTS IN HOSPITAL AND OUTPATIENT SETTINGS: THE STATUS REGISTRY
Pabinger I.	-	P-SELECTIN (P-SEL) GENE HAPLOTYPES MODULATE SOLUBLE (S) P-SEL LEVELS AND INCREASE THE RISK OF VENOUS THROMBOEMBOLISM (VTE)
	-	RISK OF RECURRENCE AFTER A FIRST VENOUS THROMBOEMBOLIC EVENT IN YOUNG WOMEN
	-	LONG-TERM PHARMACOVIGILANCE UPDATE WITH A RECOMBINANT FVIII CONCENTRATE FOR THE TREATMENT OF HEMOPHILIA A
	-	CLINICAL SIGNIFICANCE OF MICROPARTICLES
	-	SERIAL MONITORING OF ADAMTS13- AND VWF-RELATED PARAMETERS IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA: PREDICTION OF RESPONSE TO THERAPY, RISK OF RELAPSE, AND LONG-TERM COURSE
	-	A HIGH PLATELET COUNT INDEPENDENTLY PREDICTS VENOUS THROMBOEMBOLISM IN CANCER PATIENTS
	-	ANGIOTENSIN-CONVERTING ENZYME (ACE) INSERTION/DELETION (I/D) POLYMORPHISM AND SERUM LEVELS OF ACE IN VENOUS THROMBOEMBOLISM (VTE)
	-	VENOUS THROMBOEMBOLISM AND CANCER: THE PERCEIVE REGISTRY
	-	PREGNANCY OUTCOME IN WOMEN WITH THE LUPUS ANTICOAGULANT AND A HISTORY OF THROMBOEMBOLISM (TE)
	-	THE RISK FOR THROMBOEMBOLIC DISEASE IN LUPUS ANTICOAGULANT PATIENTS DUE TO PATHWAYS INVOLVING P-SELECTIN AND CD154
	-	PLATELET FUNCTION UNDER HIGH SHEAR CONDITION CORRELATES WITH CLINICAL ESTIMATION OF HEMORRHAGE IN CHRONIC AUTOIMMUNE THROMBOCYTOPENIA
	-	SUCCESSFUL PREGNANCY OUTCOME IN A WOMAN WITH HOMOZYGOUS ANTITHROMBIN DEFICIENCY (99 LEUPHE MUTATION)
	-	SOLUBLE P-SELECTIN AND THE RISK OF THROMBOTIC EVENTS IN PATIENTS WITH A LUPUS ANTICOAGULANT IN A PROSPECTIVE COHORT STUDY
Pachano S.	-	USE OF RFVIIA IN ELECTIVE SURGERY IN CASES WITH CONGENITAL COAGULOPATHIES AND INHIBITORS
Paciaroni M.	-	A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS
Pacienza N.	-	GALECTIN-1 BINDING TO PLATELETS: A NEW MECHANISM FOR PLATELET ACTIVATION
Pacienza N.A.	-	ROLE OF PPAR-GAMMA ACTIVATION IN MEGAKARYOCYTOPOIESIS
Pacienza N.	-	IMPAIRED THROMBOPOIESIS AFTER STEM CELL INFECTION WITH JUNIN VIRUS
	-	DIFFERENTIATION OF CD34+ CELLS MEDIATED BY THROMBOPOIETIN AND MONOCYTES/MACROPHAGES
Packham M.A.	-	INHIBITION OF AMINOPHOSPHOLIPID TRANSLOCASE ACTIVITY IN PHOSPHATIDYLSERINE-EXPOSING HUMAN PLATELETS IS INDEPENDENT OF CALPAIN ACTIVITY
Padankatti S.	-	POLYMORPHISMS IN COAGULANT AND INFLAMMATORY GENES MODIFY THE PHENOTYPE OF SEVERE HEMOPHILIA A AND B
Padeh S.	-	THROMBOPHILIA DOES NOT INCREASE THE RISK FOR RECURRENT THROMBOSIS IN PEDIATRIC APS
Padmore R.F.	-	MONITORING UNFRACTIONATED HEPARIN IN A PATIENT WITH RENAL AND HEPATIC INSUFFICIENCY YIELDS DISCORDANT RESULTS COMPARING ANTI-XA ASSAY AND PARTIAL THROMBOPLASTIN TIME. A CASE REPORT
Padrazzi B.	-	A MULTICENTRE PROSPECTIVE OPEN-LABEL STUDY ASSESSING PHARMACOKINETICS, CLINICAL EFFICACY AND SAFETY OF A TRIPLE-SECURED FIBRINOGEN CONCENTRATE: FIBRINOGENE T-I
Padrini R.	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
Padula G.	-	INTERACTION AND FUNCTIONAL ASSOCIATION OF PROTEIN-DISULFIDE ISOMERASE WITH V3 INTEGRIN ON ENDOTHELIAL CELLS
Pafenov A.S.	-	NORMALIZATION OF ENDOTHELIUM FUNCTIONS AS A RESULT OF HIRUDOTHRAPY
Paffen E.	-	HAPLOTYPES OF THE C-REACTIVE PROTEIN GENE, PLASMA CRP LEVELS AND THE RISK OF MYOCARDIAL INFARCTION IN MEN
	-	`IN VIVO' TOLL-LIKE RECEPTOR 4 MRNA LEVELS ARE ASSOCIATED WITH RISK OF MYOCARDIAL INFARCTION IN MEN
Paganelli F.	-	ENDOTHELIAL MARKERS OF INJURY/REPAIR EQUILIBRIUM IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY
	-	VASP PHOSPHORYLATION ANALYSIS PRIOR TO PERCUTANEOUS CORONARY INTERVENTION FOR EXCLUSION OF POST-PROCEDURAL MAJOR ADVERSE CARDIOVASCULAR EVENTS
	-	DISRUPTION OF PAI-1 CIRCADIAN RHYTHM IN OBESE SUBJECTS MAY EXPLAIN A CHANGE IN THE TIME OF ONSET OF MYOCARDIAL INFARCTION
Pagani F.	-	EVALUATION OF LIPOPROTEIN (A) IN ARGENTINIAN WOMEN WITH ADVERSED PREGNANCY OUTCOME
	-	U1SNRNP-MEDIATED RESCUE OF MRNA PROCESSING IMPAIRED BY SPLICING MUTATIONS IN SEVERE FACTOR VII DEFICIENCY
	-	ACQUIRED HEMOPHILIA A IN A PATIENT WITH HYDATID DISEASE: A CASE REPORT
Page S.	-	ACTIVATED PROTEIN C INHIBITION BY PROTEIN C INHIBITOR IS NOT ACCELERATED BY THE SYNTHETIC PENTASACCHARIDE FONDAPARINUX
Pagnan A.	-	STUDY OF PLATELETS FACTOR V UPTAKE IN HUMAN MEGAKARYOCYTE CULTURES FROM PATIENTS WITH PARAHEMOPHILIA
	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
	-	D-DIMER AS AN ADJUNCT TO COMPRESSION ULTRASONOGRAPHY IN PATIENTS WITH SUSPECTED RECURRENT IPSILATERAL DEEP VEIN THROMBOSIS. A PROSPECTIVE COHORT STUDY
	-	THROMBOPHILIA AS A PREDICTOR OF RESIDUAL VEIN THROMBOSIS. A PROSPECTIVE COHORT STUDY
	-	POLYMORPHISMS OF VON WILLEBRAND FACTOR (VWF) GENE PROMOTER MODULATE THE CORTICOSTEROID-MEDIATED INCREASE IN VWF LEVELS IN CUSHING'S SYNDROME: A POTENTIAL MODEL OF TRANSCRIPTIONAL REGULATION AND A NEW THROMBOTIC MARKER
	-	INFLUENCE OF HAEMATOCRIT ON ROTEM PARAMETERS
	-	THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM AFTER DISCONTINUING ANTICOAGULATION IN PATIENTS WITH ACUTE PROXIMAL DEEP VEIN THROMBOSIS OR PULMONARY EMBOLISM. A PROSPECTIVE COHORT STUDY
	-	RELATION BETWEEN ENDOTHELIAL AND PLATELETS MICROPARTICLES AND VENOUS THROMBOEMBOLISM: A CASE-CONTROL STUDY
	-	A NEW (I1372S) MUTATION IN THE A1 DOMAIN OF VON WILLEBRAND FACTOR ASSOCIATED WITH A TYPE 2B-LIKE VON WILLEBRAND DISEASE PHENOTYPE
	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
	-	A TYPE VICENZA-LIKE VON WILLEBRAND DISEASE NOT ASSOCIATED WITH VWF GENE MUTATION NOR ANTI-VWF ANTIBODIES
Påhlman L.I.	-	NOVEL ROLE FOR TAFI IN THE MODULATION OF HOST RESPONSES BY STREPTOCOCCI?
Pai M.	-	HIGH PREVALENCE OF IRON DEFICIENCY AMONG PATIENTS REFERRED FOR EVALUATION OF A BLEEDING DISORDER
	-	EFFICACY OF TEACHING CLINICAL CLERKS AND RESIDENTS ABOUT MANAGEMENT OF BLEEDING AND COAGULATION DISORDERS USING E-LEARNING
	-	GLOBAL ASSAYS OF PLATELET FUNCTION IN DIAGNOSTIC TESTING
Pai N.	-	EPIDEMIOLOGY OF THROMBOEMBOLISM (TE) IN CHILDREN WITH CANCER
Pais E.	-	TISSUE FACTOR-DEPENDENT COAGULANT ACTIVITY OF PLATELET-MONOCYTE COMPLEXES IN CHRONIC RENAL FAILURE (CRF). ASSOCIATION WITH HEMOSTATIC ACTIVITY, INFLAMMATION, OXIDATIVE DAMAGE AND ENDOTHELIAL DYSFUNCTION
Paiva S.G.	-	PLASMINOGEN ACTIVATOR INHIBITOR -1 (PAI-1) PLASMA LEVELS AND 4G/5G AND G844A PAI-1 PROMOTER POLYMORFISMS IN BRAZILIAN PATIENTS WITH ISQUEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE
	-	FACTOR V LEIDEN (G1691A), PROTHROMBIN (G20210A) AND METILENETETRAHYDROFOLATE
	-	PREVALENCE OF APOLIPOPROTEIN E ALLELES AND ITS ASSOCIATION WITH SERUM LIPID LEVELS IN BRAZILIAN PATIENTS WITH ISCHEMIC STROKE AND PERIPHERAL ARTERIAL DISEASE
	-	PREVALENCE OF POLYMORPHISMS IN EXONS 6 E 7 OF ABO LOCUS AND THEIR ASSOCIATION WITH VENOUS THROMBOSIS IN YOUNG BRAZILIAN PATIENTS
Pajewski N.M.	-	THE ROLE OF RACE AND ETHNICITY IN THE CLINICAL OUTCOMES OF SEVERE HEMOPHILIA A PATIENTS WITH INHIBITORS
Pakakasama S.	-	NORMALIZED PHOSPHATIDYLSERINE EXPRESSION ON RED BLOOD CELLS IN CHILDREN WITH SEVERE THALASSEMIA DISEASE AFTER STEM CELL TRANSPLANTATION
	-	THE USE OF RITUXIMAB AS AN ADJUVANT THERAPY TO INDUCE IMMUNE TOLERANCE IN CHILDREN WITH HEMOPHILIA A AND B
Palareti G.	-	HIGHER FIBRIN MONOMERS (FM) LEVELS AFTER ORAL ANTICOAGULATION (OAT) WITHDRAWAL ARE ASSOCIATED WITH INCREASED RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE
	-	INNOVANCE D-DIMER ASSAY TO ASSESS THE INDIVIDUAL RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE AFTER ANTICOAGULATION (OAT) WITHDRAWAL
	-	CLINICAL EVALUATION OF A NEW QUANTITATIVE HIGHLY SENSITIVE D-DIMER ASSAY FOR EXCLUSION OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM
	-	ISOLATED DISTAL DEEP VEIN THROMBOSIS (ID-DVT) IN THE MASTER MULTICENTER ITALIAN REGISTRY
	-	PREVALENCE OF UNPROVOKED VENOUS THROMBOEMBOLISM AND OF TRANSIENT AND PERMANENT RISK FACTORS IN DIFFERENT AGE GROUPS: RESULTS OF THE MASTER REGISTRY
	-	THE ROLE OF D-DIMER AS A RISK FACTOR FOR OCCULT CANCER AND CARDIOVASCULAR EVENTS AFTER ANTICOAGULATION WITHDRAWAL FOR A FIRST IDIOPATHIC DEEP VEIN THROMBOSIS IN THE PROLONG STUDY
	-	RESIDUAL VENOUS OBSTRUCTION AND D-DIMER AS RISK FACTORS FOR RECURRENCE AFTER ANTICOAGULATION WITHDRAWAL FOR A FIRST IDIOPATHIC DEEP VEIN THROMBOSIS IN THE PROLONG STUDY
	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE
	-	INDIVIDUAL AND CLINICAL PREDICTORS OF THE TIMING OF DIAGNOSIS OF VENOUS THROMBOEMBOLISM: RESULTS FROM THE MASTER REGISTRY
	-	THE COURSE OF D-DIMER AND FACTOR VIII LEVELS DURING THE ACUTE PHASE OF LEG DEEP VENOUS THROMBOSIS AND RELATIONSHIP WITH THE THROMBOTIC BURDEN
	-	DIFFERENT CUT-OFF VALUES OF THREE D-DIMER (DD) TESTS TO ESTABLISH DURATION OF ORAL ANTICOAGULATION TREATMENT (OAT) AFTER A VENOUS THROMBOEMBOLISM (VTE)
	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE CLINICAL STUDY
	-	DELAY IN STARTING ORAL ANTICOAGULATION IN PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM (VTE): ANALYSIS FROM THE MASTER REGISTRY
	-	COAGULATION FACTOR XI LEVELS AND THE LDL RECEPTOR-RELATED PROTEIN (LRP) GENOTYPE
	-	THE NATURAL HISTORY OF D-DIMER LEVELS IN SUBJECTS WITH NEGATIVE D-DIMER AFTER SUSPENSION OF ORAL ANTICOAGULATION FOR A FIRST EPISODE OF VENOUS THROMBOEMBOLISM: THE PROSPECTIVE OBSERVATIONAL PROLONG II STUDY
	-	G20210A PROTHROMBIN MUTATION IS MORE FREQUENT IN PATIENTS WITH ADVANCED STAGES OF PERIPHERAL ARTERIAL DISEASE (PAD)
	-	CLINICAL CHARACTERISTICS OF CANCER ASSOCIATED ACUTE VENOUS THROMBOEMBOLISM: FINDINGS FROM THE MASTER REGISTRY
	-	OUTCOME OF PATIENTS WITH SUSPECTED SYMPTOMATIC DEEP-VEIN THROMBOSIS (DVT) AND A NORMAL ULTRASOUND-BASED INITIAL DIAGNOSTIC WORKUP. A PROSPECTIVE STUDY
	-	NO INCREASED SIGNS OF ATHEROSCLEROTIC ALTERATIONS IN CARRIERS OF INHERITED THROMBOPHILIA WITH OR WITHOUT PREVIOUS VENOUS THROMBOSIS
	-	D-DIMER TESTING AND RECURRENT VENOUS THROMBOEMBOLISM AFTER UNPROVOKED PULMONARY EMBOLISM
	-	SPIRAL COMPUTED TOMOGRAPHY IN THE EVALUATION OF THE RESOLUTION OF PULMONARY EMBOLISM AFTER A STANDARD COURSE OF ANTICOAGULATION
	-	EFFECTS OF AGE AND DIFFERENT CUT-OFF VALUES ON USE OF D-DIMER (DD) TESTING TO ESTABLISH DURATION OF ORAL ANTICOAGULATION TREATMENT (OAT) AFTER VENOUS THROMBOEMBOLISM (VTE)
	-	PLASMA FIBRINOLYTIC POTENTIAL AND THE RISK OF VENOUS THROMBOEMBOLISM (VTE) RECURRENCE
Palermo M.	-	EFFECT OF ANTIINFLAMMATORY DRUGS ON HUMAN NEUTROPHILS IN ENDOTHELIAL CELL DAMAGE INDUCED BY SHIGA TOXIN-1
Palla R.	-	EFFECT OF PH AND TEMPERATURE ON ADAMTS-13 CATALYSIS
	-	DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
	-	DETERMINATION OF ANTI-ADAMTS13 AUTOANTIBODIES IN THROMBOTIC TROMBOCITOPENIC PURPURA (TTP) PATIENTS: COMPARISON OF TWO DIFFERENT METHODS
	-	PLATELET ADAMTS13 AND IN VITRO EXPRESSION STUDY OF A PATIENT AFFECTED BY CONGENITAL TTP
	-	KINETICS STUDIES OF A NATURALLY OCCURRING MUTATION ON FACTOR X (FX) GENE (G222D)
Pallotta I.	-	VON WILLEBRAND FACTOR AND GPIB-IX-V REGULATE PROPLATELETS FORMATION BY HUMAN MEGAKARYOCYTES
Palmer L.	-	COMPARISON BETWEEN CONVENTIONAL AND AUTOMATED METHODS OF RISTOCETIN COFACTOR ACTIVITY AND VON WILLEBRAND FACTOR ANTIGEN
Palmer M.	-	THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 REDUCES THROMBUS FORMATION IN A RAT MODEL
Palmerini F.	-	A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS
Palmieri V.	-	RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM
	-	INSULIN-DEPENDENT CHANGES IN PAI-1 AND T-PA LEVELS AFTER A 6-MO TREATMENT WITH R-HGH IN GROWTH HORMONE DEFICIENT (GHD) ADULTS
Palmirotta R.	-	RELATIONSHIP BETWEEN INFLAMMATORY INDEXES ON ADMISSION AND DIAGNOSIS OF ACUTE AORTIC DISSECTION
	-	OBSERVATIONAL STUDY OF 150 WOMEN WITH INHERITED THROMBOPHILIA AND RECURRENT PREGNANCY LOSS
	-	ASSOCIATION BETWEEN ENHANCED VEGF LEVELS AND PLATELET ACTIVATION IN HYPERTENSIVE PATIENTS
Palomo M.	-	ATS-13 ACTIVITY AS A COMMON MARKER OF THE ENDOTHELIAL DYSFUNCTION DEVELOPING IN THROMBOTIC MICROANGIOPATHIES OF DIFFERENT ORIGIN
	-	FLAVONOIDS INHIBIT PLATELET ADHESION AND AGGREGATION UNDER FLOW: BLOCKADE OF TXA2 RECEPTORS IN PLATELET RICH PLASMA
Palumbo L.	-	NEONATAL LENTIVIRAL GENE TRANSFER IN A KNOCK-OUT MOUSE MODEL FOR AFIBRINOGENEMIA
Pamarthi M.	-	MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII
Pampuch A.	-	DIFFERENTIAL ANALYSIS BY 2-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS (2D-DIGE) OF HUMAN PLATELET PROTEINS RELEASED FOLLOWING THROMBIN ACTIVATION: IDENTIFICATION OF LAMIN A, A NOVEL PLATELET PROTEIN
	-	PLATELET BUT NOT LEUKOCYTE ACTIVATION IS A PREREQUISITE FOR PLATELET-LEUKOCYTE INTERACTION IN HUMAN WHOLE BLOOD
	-	FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY
	-	ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS
	-	ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
	-	DETERMINANTS OF PLATELET AGGREGATE FORMATION WITH EITHER POLYMORPHONUCLEAR LEUKOCYTES OR MONOCYTES IN HUMAN WHOLE BLOOD
Pampuck A.	-	ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
Pamuklar Z.	-	PHOSPHODIESTERASE-TYPE IV REGULATES PMN/PLATELET INTERACTION IN VITRO AND PMN ACCUMULATION AT THE SITE OF VASCULAR INJURY IN VIVO
Pan W.	-	THE COOPERATIVE ACTIVITY OF THE MIDDLE AND DISTAL CARBOXYL TERMINAL DOMAINS OF ADAMTS13 IS CRUCIAL FOR BINDING VON WILLEBRAND FACTOR UNDER FLOW
Pan R.Y.	-	EVALUATION OF ORTHOSTATIC BALANCE AT GROUND AND SLOPE LEVELS IN ADULT PATIENTS WITH HAEMOPHILIA
Pan J.	-	VENOUS THROMBOEMBOLISM IN CHINA: A SINGLE-CENTER EXPERIENCE FOR 11 YEARS
Pan C.	-	SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
Pan X.	-	THE CHANGE AND MUTUAL RELATIONS BETWEEN PROTEIN Z AND PARTIAL INFLAMMATORY FACTORS IN CEREBRAL INFARCTION
Pan C.	-	PEGYLATION PROTECTS FACTOR VIII FROM THE INHIBITION OF ANTIBODY INHIBITORS
Pancaldi L.G.	-	EFFECT OF BOLUS TENECTEPLASE (TNK) ON RIGHT VENTRICULAR DYSFUNCTION IN NORMOTENSIVE PATIENTS WITH PULMONARY EMBOLISM: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Panchenko E.	-	D-DIMER IN PATIENTS WITH CLINICAL SIGNS OF ATHEROTHROMBOSIS IN DIFFERENT VASCULAR BEDS
	-	INFLUENCE OF CYP2C9 GENETIC POLYMORPHISMS ON METABOLIC CLEARANCE, WARFARIN MAINTENANCE DOSE AND BLEEDING COMPLICATIONS IN RUSSIAN PATIENTS
Pandey D.	-	ADAMTS13 ACTIVITY AND AUTOANTIBODIES IN IDIOPATHIC TTP: RESULTS FROM THE SERF-TTP GROUP
	-	RISK FACTORS FOR THROMBOTIC THROMBOCYTOPENIC PURPURA: RESULTS OF THE SURVEILLANCE, EPIDEMIOLOGY AND RISK FACTORS FOR TTP (SERF-TTP) GROUP
Pandi L.	-	PROBING THE BETA-CHAIN HOLE OF FIBRINOGEN WITH SYNTHETIC PENTAPEPTIDES THAT DIFFER ONLY AT THEIR AMINO TERMINI
Panduro L.	-	LOCAL THROMBOLYTIC THERAPY FOR ACUTE ILIOFEMORAL DEEP VENOUS THROMBOSIS IS EFFECTIVE AND PRESERVES VENOUS VALVE FUNCTION. A PROSPECTIVE ONE-CENTRE STUDY OF 86 CASES
Paneesha S.	-	WHAT DO ELEVATED D-DIMER LEVELS MEAN IN PATIENTS WITHOUT VENOUS THROMBOSIS (VTE)?
	-	WHICH PATIENTS WITH VENOUS THROMBOSIS DO NOT REQUIRE SCREENING FOR MALIGNANCY? A PREDICTIVE MODEL TO IDENTIFY PATIENTS WITH VTE AT MINIMAL RISK OF MALIGNANCY
	-	VENOUS THROMBOSIS (VTE) HAS AN ADVERSE IMPACT ON THE SURVIVAL IN PATIENTS WITH MALIGNANCY
Panes O.	-	TISSUE FACTOR-DEPENDENT COAGULANT ACTIVITY OF PLATELET-MONOCYTE COMPLEXES IN CHRONIC RENAL FAILURE (CRF). ASSOCIATION WITH HEMOSTATIC ACTIVITY, INFLAMMATION, OXIDATIVE DAMAGE AND ENDOTHELIAL DYSFUNCTION
	-	TRANEXAMIC ACID DELAYS THE CLOT LYSIS TIME, AND INCREASES THE ENDOGENOUS THROMBIN GENERATION AND PLASMA PROCARBOXYPEPTIDASE U (TAFI) LEVELS IN PATIENTS WITH MUCOCUTANEOUS BLEEDING
	-	PLASMA LEVELS OF CLOTTING FACTORS ARE POSITIVELY CORRELATED IN HEALTHY POPULATION: A COMPREHENSIVE PERSPECTIVE TO ASSESS THROMBOTIC RISK?
	-	PLASMA PROCPU (TAFI) AND CLOT LYSIS TIME ARE CORRELATED WITH CLOTTING FACTOR LEVELS AND THROMBIN GENERATION: A NOVEL APPROACH TO ASSESS THROMBOSIS RISK?
	-	INDUCTION OF TISSUE FACTOR ACTIVITY IN STIMULATED PLATELETS
Paneva D.	-	EVALUATION OF THE BEHAVIOR OF (QUATERNIZED) POLY[(2-DIMETHYLAMINO)ETHYL METHACRYLATE] AND (CROSSLINKED) N-CARBOXYETHYLCHITOSAN AND THEIR COMPLEXES IN CONTACT WITH BLOOD
Panfilov S.	-	SAFETY AND TOLERABILITY OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 IN PREVENTION OF STROKE AND OTHER THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION (AF)
Pang Y.	-	A SURVEY ON THE PREVALENCE OF VENOUS THROMBOEMBOLIC DISEASES IN GUANGZHOU OF CHINA
Paniagua C.	-	THALIDOMIDE AND THROMBOPROPHYLAXIS: TO WHOM AND WHEN
Panicca R.	-	MAXIMAL AND LATE ADP INDUCED PLATELET AGGREGATION IN CORONARY ARTERY DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY
	-	PLATELET FUNCTION EVALUATION BY USING A NEW POINT-OF-CARE SYSTEM AND PLATELET LIGHT-TRANSMISSION AGGREGATION IN A LARGE COHORT OF CORONARY ARTERY DISEASE PATIENTS
Paniccia R.	-	ASSESSMENT OF CLOT LYSIS TIME TISSUE FACTOR-INDUCED BY EXOGENOUS T-PA IN HEALTHY SUBJECTS BY USING A MICROPLATE READER
	-	ALTERED ULTRALARGE VON WILLEBRAND FACTOR LEVELS AND ADAMTS-13 ACTIVITY AFFECT RESIDUAL PLATELET REACTIVITY IN HIGH RISK VASCULAR PATIENTS ON DUAL ANTIPLATELET THERAPY
	-	POST-TREATMENT PLATELET FUNCTION PREDICTS MYOCARDIAL INJURY IN ACUTE MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PCI
	-	ASSOCIATION OF THE G681A POLYMORPHISM OF CYP2C19 GENE WITH RESPONSE VARIABILITY TO DUAL ANTIPLATELET TREATMENT IN HIGH RISK VASCULAR DISEASE PATIENTS
	-	LIPID, INFLAMMATORY AND HAEMORHEOLOGICAL PROFILES ARE SIGNIFICANTLY AFFECTED BY FARMED FISH EATING: AN INTERVENTION STUDY
	-	CLINICAL DETERMINANTS OF PLATELET FUNCTION IN PATIENTS WITH CAD UNDERGOING CORONARY ANGIOGRAPHY AND TREATED BY DUAL ANTIPLATELET THERAPY
	-	LOW RESPONSIVENESS TO CLOPIDOGREL AND STENT THROMBOSIS
Panicot-Dubois L.	-	THROMBIN-INITIATED PLATELET ACTIVATION IN VIVO IS VON WILLEBRAND FACTOR INDEPENDENT DURING THROMBUS FORMATION IN A LASER INJURY MODEL
	-	BSDL INTERACTS WITH THE PLATELET CXCR4 AND MODULATES THROMBUS FORMATION
Panizzi P.	-	VON WILLEBRAND FACTOR BINDING PROTEIN IS A NOVEL CONFORMATIONAL ACTIVATOR OF PROTHROMBIN
	-	SKIZZLE, A NOVEL PLASMIN(OGEN) BINDING PROTEIN AND PLASMINOGEN ACTIVATOR FROM STREPTOCOCCUS AGALACTIAE
	-	EXOSITES IN THE SUBSTRATE SPECIFICITY OF BLOOD COAGULATION REACTIONS
Panteleev M.A.	-	FORMATION OF SUBPOPULATIONS WITH DIFFERENT PHOSPHATIDYLSERINE EXPRESSION DURING THROMBIN-STIMULATED PLATELET ACTIVATION IS CONTROLLED BY ALPHA-GRANULE ADP SECRETION
	-	THRESHOLD BEHAVIOR OF THE BLOOD CLOTTING SYSTEM ACTIVATED BY THE TISSUE FACTOR
	-	BLOOD FLOW SUPPRESSES FEEDBACK ACTIVATION OF EXTRINSIC TENASE BY FACTOR XA AND PREVENTS CLOTTING
Panza E.	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Panzer S.	-	P-SELECTIN (P-SEL) GENE HAPLOTYPES MODULATE SOLUBLE (S) P-SEL LEVELS AND INCREASE THE RISK OF VENOUS THROMBOEMBOLISM (VTE)
	-	PLATELET FUNCTION UNDER HIGH SHEAR CONDITION CORRELATES WITH CLINICAL ESTIMATION OF HEMORRHAGE IN CHRONIC AUTOIMMUNE THROMBOCYTOPENIA
	-	THE RISK FOR THROMBOEMBOLIC DISEASE IN LUPUS ANTICOAGULANT PATIENTS DUE TO PATHWAYS INVOLVING P-SELECTIN AND CD154
	-	SOLUBLE P-SELECTIN AND THE RISK OF THROMBOTIC EVENTS IN PATIENTS WITH A LUPUS ANTICOAGULANT IN A PROSPECTIVE COHORT STUDY
Paoletti O.	-	EVALUATION OF A NEW D-DIMER METHOD
	-	LOW MOLECULAR WEIGHT HEPARIN (LMWH) BRIDGING THERAPY DURING SUBTHERAPEUTIC INR LEVELS IN VTE HIGH RISK PATIENTS
	-	ACCURACY AND COST EVALUATION OF A PORTABLE INR MONITOR
	-	PROTHROMBIN TIME: COMPARISON BETWEEN DIFFERENT REAGENTS
	-	EVALUATION OF A NEW INR PORTABLE MONITOR
	-	PT INR: COMPARISON BETWEEN TWO DIFFERENT POINT OF CARE SYSTEMS
Papac Milicevic N.	-	ISG12 REGULATES ACTIVITY OF NUCLEAR RECEPTORS THEREBY MODULATING THE VASCULAR RESPONSE TO INJURY
Papadakis E.	-	HAEMOSTATIC PROFILE OF FULL TERM HEALTHY SMALL FOR GESTATIONAL AGE (SGA) NEONATES
Papadakis E.S.	-	SECONDARY THROMBOPHYLAXIS USING ANTIPLATELET AGENTS AND LONG TERM MONITORING AFTER 1ST UNPROVOKED EPISODE OF VENOUS THROMBOEMBOLISM
Papaioannou G.	-	SECONDARY THROMBOPHYLAXIS USING ANTIPLATELET AGENTS AND LONG TERM MONITORING AFTER 1ST UNPROVOKED EPISODE OF VENOUS THROMBOEMBOLISM
	-	HAEMOSTATIC PROFILE OF FULL TERM HEALTHY SMALL FOR GESTATIONAL AGE (SGA) NEONATES
Papalardo E.	-	EFFECTS OF AN INHIBITOR OF NUCLEAR FACTOR-KAPPA B (NF-KB) ON THROMBOGENIC PROPERTIES OF ANTIPHOSPHOLIPID ANTIBODIES IN VIVO
Papamichos S.I.	-	COINHERITANCE OF FV-LEIDEN MUTATION AND FV-HR2
	-	EPIDEMIOLOGICAL STUDY: CAUSES OF DETHS IN PTOLEMAIDA CITY
	-	EVALUATION OF PRO-TIME MICROCOAGULLATION SUSTEM
	-	DIETARY EFFECT ON VITAMIN K-DEPENDED COAGULATION FACTORS AND ON PLATELETS' AGGREGATION
Papassotiriou I.	-	CIRCULATING LEVELS OF ADHESION MOLECULES AND MARKERS OF ENDOTHELIAL DYSFUNCTION IN ACUTE INFLAMMATION INDUCED BY PROLONGED BRISK EXERCISE: RAPID ENDOTHELIAL RECOVERY AND POTENTIAL BENEFICIAL EFFECTS
	-	LONGITUDINAL COURSE AND CLINICAL SIGNIFICANCE OF TGF-B1, SL- AND SE-SELECTINS AND SICAM-1 LEVELS DURING SEVERE ACUTE STRESS IN CHILDREN
Papayan K.A.	-	HOMOCYSTEINE LEVELS AND PREVALENCE OF C677T POLYMORPHISM IN METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) GENE IN CHILDREN WITH MIGRAINE
Papayan L.P.	-	APOE GENE POLYMORPHISM CAN MODIFY THE RISK OF VENOUS THROMBOEMBOLISM
	-	THE ROLE OF DNA POLYMORPHISMS IN GENES CODING THE HOMOCYSTEINE AND FOLATE METABOLIZING ENZYMES IN ISCHAEMIC HEART DISEASE
	-	GENETIC POLYMORPHISM OF THE PLATELET ADP-RECEPTOR P2Y12 MODIFIES THE RISK OF PULMONARY EMBOLISM IN PATIENTS WITH DEEP-VEIN THROMBOSIS
	-	INFLUENCE OF HYPERHOMOCYSTEINEMIA ON FIBRINOLYTIC AND ANTICOAGULANT SYSTEMS IN PATIENTS WITH ACUTE CORONARY SYNDROME
	-	HYPERHOMOCYSTEINEMYA IS COMMON IN ACUTE CORONARY SYNDROMES IN NORTH-WESTERN RUSSIA
Papiewska-Pajak I.	-	REGULATORY EFFECT OF ALPHA1-ACID GLYCOPROTEIN ON PAI-1 REDISTRIBUTION ON ENDOTHELIAL CELLS SURFACE
Papini S.	-	A PROPOSAL OF SCORING SYSTEM IN ASSESSMENT OF THROMBOTIC RISK IN CANCER PATIENT. A MONOCENTRIC STUDY
Papp Z.	-	THE OCCURRENCE OF FACTOR V LEIDEN MUTATION IN HUNGARIAN HELLP SYNDROME PATIENTS
	-	STUDY OF THE METHYLENETETRAHYDROFOLATE REDUCTASE C677T POLYMORPHISM IN HELLP SYNDROME PATIENTS
Papp M.	-	QUANTITATION OF VON WILLEBRAND FACTOR MULTIMER DISTRIBUTION BY DENSITOMETRY
	-	VWF FUNCTIONS, ADAMTS-13 ACTIVITY AND ANTIGEN LEVELS IN PATIENTS WITH LIVER CIRRHOSIS
Paques M.	-	ABNORMALITIES IN THE SEROTONIN METABOLISM: A PATHOGENIC HYPOTHESIS FOR CENTRAL RETINAL VEIN OCCLUSION (CRVO)
Paquet N.	-	IMMUNE RESPONSE AFTER FIRST AND SECOND IV INJECTION OF AVIDIN USED AS THE NEUTRALIZING AGENT FOR BIOTINYLATED IDRAPARINUX
	-	NEUTRALIZATION BY AVIDIN OF ANTICOAGULANT ACTIVITY OF BIOTINYLATED IDRAPARINUX, THE FIRST AND UNIQUE REVERSIBLE LONG-ACTING ANTICOAGULANT
Parahuleva M.S.	-	THE DISTRIBUTION OF FACTOR SEVEN ACTIVATING PROTEASE (FSAP) IN CAROTID AND CORONARY ATHEROSCLEROTIC PLAQUES IN SUBJECTS GENOTYPED FOR THE MARBURG I POLYMORPHISM
Páramo J.A.	-	SPANISH CONSENSUS STATEMENT ON PHARMACOLOGIC ALTERNATIVES TO ALLOGENEIC BLOOD TRANSFUSIONS: THE SEVILLE'S DOCUMENT*
Paramo J.A.	-	EFFECT OF AGING ON PLASMINOGEN ACTIVATOR INHIBITOR-1 EXPRESSION IN RAT TISSUES. POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND CARDIOVASCULAR RISK
	-	THROMBIN INDUCES MMP-10 IN HUMAN ENDOTHELIAL CELLS: PATHOPHYSIOLOGICAL IMPLICATIONS IN DISSEMINATED INTRAVASCULAR COAGULATION
	-	CYTOKINE-INDUCED MONOCYTE-ENDOTHELIAL CELL INTERACTIONS: EFFECT ON PAI-1 LEVELS
Pardal E.	-	LONG TERM ANTICOAGULATION WITH FONDAPARINUX FOR DIALYSIS DEPENDENT PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
Parent F.	-	TREATMENT OF VTE DURING PREGANCY WITH A ONCE-DAILY REGIMEN OF LMWH
Pareyn I.	-	NOVEL INTERACTING PROTEINS WITH PLATELET 21 CYTOPLASMIC TAILS: RHOGDI AND SLAP-2
	-	THE A/T1381 POLYMORPHISM IN THE A1-DOMAIN OF VON WILLEBRAND FACTOR INFLUENCES THE AFFINITY OF VON WILLEBRAND FACTOR FOR PLATELET GLYCOPROTEIN IB-ALPHA
	-	RESTORATION OF VON WILLEBRAND FACTOR FUNCTION IN A MURINE MODEL OF SEVERE VON WILLEBRAND DISEASE AFTER LIVER SPECIFIC GENE TRANSFER
	-	THE DISTURBED MULTIMER PATTERN OF VWF R1374C IS NOT DUE TO INCREASED ADAMTS13 MEDIATED PROTEOLYSIS
Pargalava N.N.P.	-	APPLICATION OF LOW MOLECULAR-WEIGHT HEPARIN (NARDROPARINE) IN PATIENTS WITH LUNG CANCER
Pargalava N.	-	THE USE OF LOW-MOLECULAR HEPARIN IN PRAGNANTS
Parhami-Seren B.	-	THE INFLUENCE OF VON WILLEBRAND FACTOR (VWF) ON FACTOR VIII (FVIII) ACTIVITY IN PLASMA
Pariente J.A.	-	REACTIVE OXYGEN SPECIES GENERATION IS REQUIRED FOR THROMBIN-INDUCED PLATELET APOPTOSIS
Parise P.	-	SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION
Parisi R.	-	PREVENTION OF RECURRENT THROMBOEMBOLISM BY ADJUSTING THE DURATION OF ANTICOAGULATION ACCORDING TO RESIDUAL VEIN THROMBOSIS. A RANDOMIZED STUDY
Parisi G.	-	LIPID, INFLAMMATORY AND HAEMORHEOLOGICAL PROFILES ARE SIGNIFICANTLY AFFECTED BY FARMED FISH EATING: AN INTERVENTION STUDY
Park E.	-	EMODIN INHIBITS PDGF-BB-STIMULATED VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY BLOCKING OF PDGF BETA-RECEPTOR PHOSPHORYLATION
Park H.	-	PROGNOSTIC SIGNIFICANCE OF THE POLYMORPHISMS IN METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR C677T) AND THYMIDYLATE SYNTHASE ENHANCER REGION (TSER) GENE IN EPILEPSY
Park M.	-	ACUTE THROMBOSIS IN A PATIENT WITH ACQUIRED FVIII INHIBITOR: CASE REPORT
Park E.	-	ANTIPLATELET ACTIVITY OF FENOFIBRATE, A PPARALPHA AGONIST, WAS MEDIATED BY BLOCKING OF CYTOSOLIC CALCIUM MOBILIZATION AND THROMBOXANE A2 RECEPTOR
Park S.	-	PLASMA LEVEL OF STROMAL DERIVED FACTOR-1 (SDF-1) IS INCREASED IN DISSEMINATED INTRAVASCULAR COAGULATION PATIENTS WHO HAVE A POOR OUTCOME: IN VITRO EFFECT OF SDF-1 ON COAGULOPATHY
Park C.	-	PREVALENCE OF ASPIRIN RESISTANCE MEASURED BY TWO RAPID PLATELET FUNCTION ANALYZERS
Park D.	-	PREVALENCE OF ASPIRIN RESISTANCE MEASURED BY TWO RAPID PLATELET FUNCTION ANALYZERS
Park S.	-	PREVALENCE OF ASPIRIN RESISTANCE MEASURED BY TWO RAPID PLATELET FUNCTION ANALYZERS
Park S.S.	-	CHANGES OF THE PLASMA LEVELS OF PLATELET AND ENDOTHELIAL MICROPARTICLES IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND ANTIHOSPHOLIPID SYNDROME
Park H.	-	GENDER-SPECIFIC ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR POLYMORPHISMS (VEGF -2578CA AND -634GC) AND THE RISK OF ISCHEMIC STROKE
Park S.	-	GENDER-SPECIFIC ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR POLYMORPHISMS (VEGF -2578CA AND -634GC) AND THE RISK OF ISCHEMIC STROKE
Park H.	-	C936T MUTATION IN THE VEGF GENE AS AN INDEPENDENT RISK FACTOR FOR PATIENTS WITH SILENT BRAIN INFARCTION
Park C.	-	ESTABLISHMENT OF REFERENCE INTERVALS OF PLATELET FUNCTION ANALYZER-100 CLOSURE TIMES IN HEALTHY KOREAN ADULTS
Park E.	-	ANTIPLATELET ACTIVITY OF EPIGALLOCATECHIN GALLATE IS MEDIATED BY THE INHIBITION OF PLCGAMMA2 PHOSPHORYLATION, ELEVATION OF PGD2 PRODUCTION AND MAINTENANCE OF CALCIUM-ATPASE PUMP
	-	THE RELATIONSHIP OF P2Y1 ADP RECEPTOR POLYMORPHISMS AND ISCHEMIC VASCULAR DISEASE
Park S.	-	THE RELATIONSHIP OF P2Y1 ADP RECEPTOR POLYMORPHISMS AND ISCHEMIC VASCULAR DISEASE
	-	THE RELATIONSHIP OF P2Y1 ADP RECEPTOR POLYMORPHISMS AND ISCHEMIC VASCULAR DISEASE
Park J.	-	THE RELATIONSHIP OF P2Y1 ADP RECEPTOR POLYMORPHISMS AND ISCHEMIC VASCULAR DISEASE
Park S.	-	THE RELATIONSHIP OF P2Y1 ADP RECEPTOR POLYMORPHISMS AND ISCHEMIC VASCULAR DISEASE
Park R.	-	BIOCHEMICAL ANALYSIS OF RECOMBINANT FIBRINOGEN AALPHAGLN328PRO; PREVIOUSLY REPORTED AS FIBRINOGEN VARIANT SEOUL II WITH IMPAIRED FIBRIN ALPHA-CHAIN CROSS-LINKING
Parker A.L.	-	HEPATIC TARGETING OF ADENOVIRUS MEDIATED BY COAGULATION FACTOR X
Parker E.T.	-	COMPARISON OF HUMAN RFVIII AND MURINE RFVIII IN A STANDARDIZED FVIII DEPENDENT BLEED MODEL IN FVIII -/- MICE
	-	FUNCTIONAL CHARACTERIZATION OF STRUCTURAL EPITOPES IN THE C2 DOMAIN OF FACTOR VIII
Parkin M.	-	QUALITY OF ANTICOAGULATION MANAGEMENT IN PRIMARY CARE PRACTICE
Parks T.	-	GLYCOPROTEIN IIB/IIIA RECEPTOR DENSITY MEASUREMENT. IMPLICATIONS IN THE MONITORING OF ANTIPLATELET DRUGS
Parmar N.	-	DETERMINATION OF THROMBIN-ALPHA2MACROGLOBULIN COMPLEXES BY A NEW IMMUNO-ACTIVITY ASSAY
	-	INFLUENCE OF COVALENT ANTITHROMBIN-HEPARIN COMPLEX ON FIBROBLAST GROWTH FACTOR EXPRESSION AND LUNG ANGIOGENESIS
	-	COVALENT ANTITHROMBIN-HEPARIN COMPLEX NEUTRALIZES PROCOAGULANT ACTIVITY INDUCED BY VENTILATION IN NEWBORNS
Parmathi M.	-	SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
Parmenter C.D.J.	-	DEFINING THE STRUCTURE OF MEMBRANE-BOUND HUMAN BLOOD COAGULATION FACTOR VA
	-	3D STRUCTURES OF MEMBRANE-BOUND FACTOR VIII
	-	A CRYO-ELECTRON MICROSCOPY STUDY OF RECOMBINANT FVIII BINDING TO PS LIPOSOMES
Parolari A.	-	TISSUE FACTOR INDUCTION BY PROTEASE-ACTIVATED RECEPTOR-1 REQUIRES INTACT CAVEOLIN-ENRICHED MEMBRANE MICRODOMAINS IN HUMAN ENDOTHELIAL CELLS
	-	EVALUATION OF THE EFFECT OF TWO DIFFERENT DOSES OF ASPIRIN IN PATIENTS UNDERGOING CABG
Parrilla R.	-	INTEGRIN-LINKED KINASE (ILK) IN PLATELET ALPHAIIB-BETA3 SIGNALING AND ARTERIAL THROMBOSIS
	-	CORRELATION BETWEEN SCD40L LEVELS AND METALLOPROTEINASE EXPRESSION WITH THE PLATELET FUNCTIONAL RESPONSE IN IMMUNOLOGICAL DISEASES
Parrinello G.	-	TISSUE FACTOR AND COAGULATION FACTOR VII LEVELS DURING ACUTE MYOCARDIAL INFARCTION CONTRIBUTE TO PREDICT MORTALITY AND RE-INFARCTION
Parry T.J.	-	EFFECTS OF JNJ-28045446 ON P2Y12 ADP RECEPTOR FUNCTION IN VITRO AND IN VIVO
Parsi K.	-	EFFECT OF SCLEROSANTS ON ANTITHROMBOTIC MECHANISMS, ENDOTHELIAL CELLS AND FIBRINOLYSIS
Parsons N.	-	WHICH PATIENTS WITH VENOUS THROMBOSIS DO NOT REQUIRE SCREENING FOR MALIGNANCY? A PREDICTIVE MODEL TO IDENTIFY PATIENTS WITH VTE AT MINIMAL RISK OF MALIGNANCY
Parviz B.	-	THE DISTRIBUTION OF FACTOR SEVEN ACTIVATING PROTEASE (FSAP) IN CAROTID AND CORONARY ATHEROSCLEROTIC PLAQUES IN SUBJECTS GENOTYPED FOR THE MARBURG I POLYMORPHISM
Pasalar P.	-	RARE COAGULATION DISORDERS IN ISFAHAN HEMOPHILIA CENTER
Pascual C.	-	HEPARIN-INDUCED THROMBOCYTOPENIA IN A PATIENT WITH POLYCYTEMIA VERA: A THREATENING ASSOCIATION
Pasi J.	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
Paskaleva I.	-	FREQUENCIES OF CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5, MDR1 ALLELIC VARIANTS IN PATIENTS WITH DIFFERENT ACENOCOUMAROL DOSE REQUIREMENTS
Paskas S.	-	THROMBIN INDUCES ACTIVATION OF MATURED DENDRITIC CELLS VIA RHO/ERK PATHWAYS
Pasowicz M.	-	REDUCED CLOT PERMEABILITY AND SUSCEPTIBILITY TO LYSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME: EFFECTS OF INFLAMMATION AND OXIDATIVE STRESS
Pasquali V.	-	COAGULATION FACTOR VII LEVELS ARE MODULATED BY THE BIOLOGICAL CLOCK
Pasqui A.	-	INFLUENCE OF LECTIN-LIKE OX-LDL RECEPTOR-1 (LOX-1) AND NITRIC OXIDE SINTHASE (NOS) POLYMORPHISMS IN ATORVASTATIN ANTITHROMBOTIC ACTION AND CARDIOVASCULAR EVENTS RATE
Passera R.	-	LONG TERM OUTCOMES OF DEEP-VEIN THROMBOSIS IN ASIA AFTER MAJOR ORTHOPEDIC SURGERY: THE AIDA EXTENSION STUDY
Pasterkamp G.	-	CD36 AND SRA GENE EXPRESSION IN HUMAN CAROTID ENDARTERECTOMY LESIONS
Pasternack R.	-	DETERMINATION OF PLASMA COAGULATION FACTOR XIII WITH THE NOVEL FLUOROGENIC ISOPEPTIDASE ASSAY
Pastorelli M.	-	INFLUENCE OF LECTIN-LIKE OX-LDL RECEPTOR-1 (LOX-1) AND NITRIC OXIDE SINTHASE (NOS) POLYMORPHISMS IN ATORVASTATIN ANTITHROMBOTIC ACTION AND CARDIOVASCULAR EVENTS RATE
Pastorello M.	-	RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS
Pastorova V.E.	-	ANTITHROMBOTIC EFFECT OF ADENOSINTHREEPHOSPHATE AT INTRODUCTION BY AN ANIMALS WITH DISTURB OF HAEMOSTATIC SYSTEM
Patarroyo-White S.	-	AV513 ENHANCES TISSUE FACTOR ACTIVITY AND STIMULATES THROMBIN GENERATION IN HEMOPHILIA A PLASMA
	-	PRECLINICAL PHARMACOLOGY OF AV513 INCLUDING ORAL EFFICACY IN SEVERE HEMOPHILIA A DOGS
Patel R.	-	PLATELET DENSE GRANULE SECRETION ACCELERATES THE DEVELOPMENT OF ARTERIOSCLEROSIS AFTER VASCULAR INJURY
Patel C.	-	HEMODIALYSIS DOWN REGULATES THE INFLAMMATORY MEDIATORS IN PATIENTS WITH END STAGE RENAL DISEASE
Patel K.D.	-	BLOOD EOSINOPHILS STORE AND EXPOSE TISSUE FACTOR (TF) PROMOTION OF TRANSENDOTHELIAL MIGRATION
Patel K.	-	PREVALENCE OF CROSS-REACTIVE EPITOPES TO BOVINE FACTOR VA LIGHT CHAIN FRAGMENTS IN NORMALS AND END STAGE RENAL DISEASE PATEINTS
Patel C.	-	FIBRINOLYTIC DEFICIT CONTRIBUTES TO THE THROMBOTIC COMPLICATIONS IN END STAGE RENAL DISEASE. PROFILING OF PLASMINOGEN ACTIVATOR INHIBITOR, TISSUE PLASMINOGEN ACTIVATOR, FACTOR XIII THROMBIN ACTIVATABLE FIBRINOLYTIC INHIBITOR, AND ALPHA2 ANTIPLASMIN
Patel R.	-	USE OF RECOMBINANT ACTIVATED FACTOR VIIA (RFVIIA) IN MASSIVE HAEMORRHAGE
Patel S.	-	MECHANICS OF PROPLATELET ELABORATION
Patel C.	-	POTENTIAL ROLE OF ADAMTS13/FXI COMPLEXES IN THE PATHOGENESIS OF ESRD
Patel S.	-	CHEMOTHERAPY AFFECTS ACTIVATED PROTEIN C GENERATION TO A GREATER DEGREE IN NEWBORN THAN IN ADULT PLASMA
	-	EFFECT OF AGE ON THE RELATIONSHIP BETWEEN RATE OF HEPARIN-CATALYZED INHIBITION OF COAGULATION FACTORS BY ANTITHROMBIN AND IN VIVO PLASMA CONCENTRATION
Patel D.	-	PHARMACOKINETICS AND DOSE-FINDING OF FRAGMIN IN PEDIATRIC PATIENTS AT RISK FOR THROMBOEMBOLIC EVENTS
Paterson A.D.	-	IDENTIFICATION OF A LOCUS FOR THE QUEBEC PLATELET DISORDER USING GENETIC LINKAGE ANALYSIS
Pathare A.	-	CLINICAL PROFILE AND MOLECULAR BASIS OF GLANZMANN'S THROMBASTHENIA [GT] IN THE SULTANATE OF OMAN
Patil S.B.G.	-	INHIBITION OF THROMBOSIS BY AZD6140 VIA SELECTIVE BLOCKADE OF THE P2Y12 RECEPTOR IN A MURINE LASER-INJURY MODEL
Patil G.	-	INHIBITION OF CANCER AND INFLAMMATION-ASSOCIATED THROMBOSIS USING NOVEL INHIBITORS OF NFKB AND OXIDATIVE STRESS PATHWAYS
Patnaik M.M.	-	DOES TESTING FOR ANTI BETA-2 GLYCOPROTEIN 1 ANTIBODIES ALTER CLINICAL PRACTICE IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME?
Patno T.	-	CLINICAL APPLICATIONS OF A DIRECT GENOMIC PLATFORM FOR SNP DETECTION IN HUMAN DNA SAMPLES USING GOLD NANOPARTICLE PROBE TECHNOLOGY AND ENHANCED SIGNAL AMPLIFICATION
Paton C.M.	-	FIBRIN A-ALPHA PEPTIDE MEDIATED DELIVERY OF BIOLOGICALLY ACTIVE PROTEINS
Patonay G.	-	MULTIMODALITY INTRAOPERATIVE IMAGING OF THROMBI IN THICK-WALLED BLOOD VESSELS OF LARGE ANIMALS USING NEAR INFRARED FLUORESCENCE
Patrignani N.	-	HEPARIN-INDUCED THROMBOCYTOPENIA IN A PATIENT WITH POLYCYTEMIA VERA: A THREATENING ASSOCIATION
Patrone L.	-	EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED TREATMENT
	-	EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED PREVENTION
Patrono C.	-	OXIDATIVE STRESS AND PLATELET ACTIVATION IN SUBJECTS WITH MODERATE HYPERHOMOCYSTEINEMIA DUE TO MTHFR 677 C-T POLYMORPHISM
	-	DETERMINANTS OF PLATELET ACTIVATION IN HEART FAILURE
Patrushev L.I.	-	PREVALENCE OF FACTOR V LEIDEN, PROTHROMBIN G20210A, AND 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE C677T GENE MUTATIONS IN A HEALTHY RUSSIAN POPULATION
Pattacini C.	-	A SUCCESSFUL IMMUNOMODULATION-ITI RESCUE IN SEVERE HAEMOPHILIA A WITH HIGH RESPONDER INHIBITOR
Pattanapanyasat K.	-	POTENTIAL FACTORS WHICH MAY CAUSE A HIGH LEVEL OF ACA IGG AND IGM
Patten I.S.	-	PEROXIREDOXIN, PRDX1 PLAYS AN IMPORTANT ROLE IN INFLAMMATION AND EARLY ATHEROSCLEROSIS
Patterson C.	-	LACK OF ASSOCIATION OF ANTIPHOSPHOLIPID ANTIBODIES WITH CORONARY ATHEROSCLEROSIS IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
Pattison A.	-	LOCAL ISI CALIBRATION AND "DIRECT INR" IN CORRECTION OF REPORTED INTERNATIONAL NORMALISED RATIOS: AN INTERNATIONAL STUDY
Patton W.F.	-	HEPARIN INDUCED THROMBOCYTOPENIA: COMPLIANCE WITH GUIDELINES IN A LARGE COMMUNITY HOSPITAL
Pattou F.	-	ANTITHROMBIN REDUCES COAGULATION AND INFLAMMATION IN A PIG MODEL OF ISLET TRANSPLANTATION
Paty I.	-	BIOEQUIPOTENCY OF IDRAPARINUX AND BIOTINYLATED IDRAPARINUX AFTER SINGLE DOSE IN HEALTHY SUBJECTS
	-	NEUTRALIZATION BY AVIDIN OF ANTICOAGULANT ACTIVITY OF BIOTINYLATED IDRAPARINUX, THE FIRST AND UNIQUE REVERSIBLE LONG-ACTING ANTICOAGULANT
	-	IMMUNE RESPONSE AFTER FIRST AND SECOND IV INJECTION OF AVIDIN USED AS THE NEUTRALIZING AGENT FOR BIOTINYLATED IDRAPARINUX
Paul S.	-	A COVALENT REACTIVE ANTIGEN ANALOG TO FACTOR VIII REDUCES ANTIBODY PRODUCTION IN MEMORY B CELLS AFTER RE-STIMULATION WITH FVIII
Paul J.	-	FIBRIN DEPOSITION ACCELERATES NEUROVASCULAR DAMAGE AND NEUROINFLAMMATION IN MOUSE MODELS OF ALZHEIMER'S DISEASE
Paulin D.	-	RESISTANCE TO OAC ASSOCIATED TO A NEW POINT MUTATION IN VKORC1 GENE
Paunio M.	-	BLOOD GROUP AB AND FV LEIDEN AS RISK FACTORS FOR PRE-ECLAMPSIA
Pauschinger M.	-	VIRAL MYOCARDITIS IS A HYPERCOAGULATIVE STATE. INCREASED TISSUE FACTOR EXPRESSION AND PLASMA THROMBOGENICITY
Pautard B.	-	SERIOUS BLEEDS IN HAEMOPHILIAC A CHILDREN AND CONTINUOUS INFUSION (CI)
Pautas E.	-	OVER-ANTICOAGULATION ASSOCIATED WITH COMBINED USE OF COUMARIN ANTICOAGULANTS AND TOPICAL ECONAZOLE OR BIFONAZOLE IN ELDERLY PATIENTS
	-	SPECIFIC MULTI-RULE EXPERT SYSTEM FOR ELDERLY INPATIENT ANTICOAGULANT CONTROL
	-	IS MODIFICATION OF DIET IN RENAL DISEASE (MDRD) FORMULA SIMILAR TO COCKCROFT-GAULT FORMULA TO ASSESS RENAL FUNCTION IN ELDERLY HOSPITALIZED PATIENTS TREATED WITH LOW MOLECULAR WEIGHT HEPARIN (LMWH)?
Pavesi G.	-	INTRACRANIAL STENTING IN FOUR PATIENTS WITH ACUTE ISCHEMIC STROKE
Pavic M.	-	INHERITED PROTHROMBOTIC RISK FACTORS IN CHILDREN WITH CEREBROVASCULAR DISORDERS
Pavlova B.	-	EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED PREVENTION
	-	EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED TREATMENT
Pavlova A.	-	GENETIC BASIS OF ACQUIRED HAEMOPHILIA
Pavlova O.	-	RELATIONSHIP BETWEEN CIRCULATING THROMBOMODULIN LEVELS AND LATENT PROGRESSION OF ATHEROSCLEROSIS IN TYPE 2 DIABETIC PATIENTS
	-	RELATIONSHIP BETWEEN ENDOTHELIAL HAEMOSTATIC MARKERS IN TYPE 2 DIABETIC PATIENTS
Pavlova A.	-	PSEUDO-HOMOZYGOUS APC RESISTANCE DUE TO COINHERITANCE OF HETEROZYGOUS FACTOR V-R506Q AND FV TYPE I DEFICIENCY
Pawlak D.	-	VALIDATION OF AN IMPROVED PRION AND VIRUS ELIMINATION PROCESS IN THE MANUFACTURE OF BOVINE THROMBIN, A TOPICAL HEMOSTAT USED IN SURGERY
Pawlak K.	-	ACTIVATION OF INTRAVASCULAR COAGULATION DURING HEMODIALYSIS WITH DIFFERENT HEPARINS: A CROSS-OVER STUDY
Pawlak D.	-	FACTOR V REMOVAL FROM BOVINE THROMBIN USED AS A TOPICAL HEMOSTAT IN SURGERY: IMPROVED PURITY THROUGH A NEW MANUFACTURING PROCESS
Pawlak K.	-	HEPCIDIN IN HEMODIALYZED AND PERITONEALLY DIALYZED PATIENTS: A LINK BETWEEN ANEMIA AND INFLAMMATION?
Pawlak D.	-	THE PROTHROMBOTIC AND HYPERTENSIVE EFFECTS OF ANGIOTENSIN(1-9) IN RATS MAY BE MEDIATED BY ANGIOTENSIN II
Pawlak K.	-	ADIPOCYTOKINES AND VASCULAR ENDOTHELIUM IN DIABETIC AND NON-DIABETIC PERITONEALLY DIALYZED PATIENTS
Pawlowska Z.	-	EFFECT OF NATRIURETIC PEPTIDES ON ANGIOGENIC PROPERTIES OF HUMAN ENDOTHELIAL CELLS
	-	DIAMOND PARTICLES OF MICROMETRIC SIZE ARE INTERNALIZED BY ENDOTHELIAL CELLS
Payer S.	-	ENDOGENOUS THROMBIN POTENTIAL IN 3183 PARTICIPANTS OF THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY
Payne C.D.	-	EFFECT OF PRASUGREL AND HIGH DOSE CLOPIDOGREL ON PLATELET FUNCTION AS ASSESSED BY POINT OF CARE AND OPTICAL AGGREGOMETRY
	-	INDIVIDUAL AND COMBINED EFFECTS OF ASPIRIN AND THIENOPYRIDINES IN ATTENUATION OF PLATELET AGGREGATION INDUCED BY COLLAGEN AND OTHER AGONISTS
Payrastre B.	-	THE GPIB-V-IX COMPLEX FACILITATES PLATELET PROCOAGULANT ACTIVITY INDEPENDENTLY OF THE GPIB ALPHA NH2 TERMINAL DOMAIN
	-	ROLES OF THE C-TERMINAL TYROSINE RESIDUES OF LAT IN GPVI-INDUCED PLATELET ACTIVATION; INSIGHT INTO THE MECHANISM OF PLC GAMMA2 ACTIVATION
	-	DEFICIENCY OF SRC HOMOLOGY 2 DOMAIN-CONTAINING INOSITOL 5-PHOSPHATASE 1 (SHIP1) AFFECTS PLATELET RESPONSES AND THROMBUS GROWTH
Paz B.	-	EFFECT OF FIBRIN MATRICES ON INCREASED PROLIFERATION AND SPREADING OF EARLY TERM TROPHOBLASTS AND PLACENTAL VILLI. MODULATION OF COAGULATION AND ANGIOGENESIS FUNCTIONS
Pazdan A.	-	C-REACTIVE PROTEIN, LIPOPROTEIN(A) AND HOMOCYSTEINE AS CONTRIBUTORS TO FIBRIN CLOT PERMEABILITY AND LYSABILITY IN SUBJECTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING
	-	FOLIC ACID ADMINISTRATION AND PLATELET ACTIVATION AT THE SITE OF MICROVASCULAR INJURY IN SUBJECTS WITH ELEVATED TOTAL HOMOCYSTEINE
Peachey A.R.	-	CONSTITUTIVELY ACTIVE OR INACTIVE I DOMAINS AS PROBES FOR INTEGRIN BINDING TO COLLAGEN
Peake I.	-	TYPE 1 VON WILLEBRAND DISEASE (VWD)
Peake I.R.	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
Peake I.	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
	-	VICENZA MUTATION R1205H IDENTIFIED IN TWO TYPE 1 VON WILLEBRAND DISEASE FAMILIES FROM ISRAEL
Peake I.R.	-	THE ISTH SSC VON WILLEBRAND FACTOR (VWF) ONLINE DATABASE
Peake I.	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
Pearce A.C.	-	A GADS-INDEPENDENT PATHWAY OF PLCGAMMA2 REGULATION DOWNSTREAM OF THE COLLAGEN RECEPTOR, GPVI
	-	PLATELET ITIM PROTEINS INHIBIT BASAL SIGNALLING BY YXXL-CONTAINING PLATELET ACTIVATION RECEPTORS
	-	THE PLATELET ACTIVATION C-TYPE LECTIN RECEPTOR CLEC-2 SIGNALS VIA A NOVEL YXXL DEPENDENT SIGNALLING CASCADE DISTINCT FROM THAT OF ITAM RECEPTORS
	-	NOVEL PLATELET MEMBRANE RECEPTORS AND SIGNALLING PROTEINS
Pearson J.	-	ENDOTHELIAL PROGENITOR CELLS
Pease R.J.	-	TISSUE TRANSGLUTAMINASE DOES NOT STABILIZE ARTERIAL PLAQUES IN THE APOE DEFICIENT MOUSE
	-	SECRETION OF COAGULATION FACTOR XIIIA FROM HAEMATOPOIETIC CELLS
Pecce R.	-	INHIBITION BY SOY ISOFLAVONES OF HUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTION
	-	ANTI-INFLAMMATORY EFFECS OF CLOPIDOGREL IN THE MOUSE
	-	PHOSPHODIESTERASE-TYPE IV REGULATES PMN/PLATELET INTERACTION IN VITRO AND PMN ACCUMULATION AT THE SITE OF VASCULAR INJURY IN VIVO
	-	PERSISTENT PLATELET ACTIVATION IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LOW DOSES OF ASPIRIN
Pecci A.	-	MARKED EMPERIPOLESIS AND INCREASED P-SELECTIN EXPRESSION ON MEGAKARYOCYTES IN A NOVEL CASE OF GRAY PLATELET SYNDROME
	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
	-	VON WILLEBRAND FACTOR AND GPIB-IX-V REGULATE PROPLATELETS FORMATION BY HUMAN MEGAKARYOCYTES
Pecheniuk N.M.	-	RECURRENT VENOUS THROMBOEMBOLISM LINKED TO LOW PLASMA HDL
Pechlaner C.	-	UNEXPLAINED HIGH D-DIMER
Pecka M.	-	ACETYLSALICYLIC ACID (ASA) RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE (IHD) AS BIOINDICATOR OF THE TREATMENT STRATEGY
	-	MODIFIED PLATELETS FUNCTION ANALYSIS TO RATIONALIZE CHOLESTEROL ELIMINATION PROCEDURE
	-	HAEMOSTATS BONDED WITHIN INTERMOLECULAR COMPLEXES AND THEIR EFFECT ON PLATELET COUNT DECREASE IN ANTICOAGULATED BLOOD
Pecka M.M.P.	-	FREQUENCY OF F II20210A IN WOMEN WITH VENOUS THROMBOEMBOLISM IN ASSOCIATION WITH ORAL CONTRACEPTIVE USE
Pecka M.	-	CONFIRMATION OF EFFICACY, SAFETY AND COST EFFECTIVENESS OF FRAXIPARINE FORTE IN THE OUTPATIENT TREATMENT OF DEEP VENOUS THROMBOSIS
Pecoraro C.	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Pedaries C.	-	A GADS-INDEPENDENT PATHWAY OF PLCGAMMA2 REGULATION DOWNSTREAM OF THE COLLAGEN RECEPTOR, GPVI
Pedersen H.D.	-	EFFECT OF MICROSPHERE EMBOLI ON THE VENTILATION-PERFUSION RELATIONSHIP IN THE RABBIT - A PILOT STUDY
Pedersen S.	-	LATE BREAKING CLINICAL TRIALS- BIOPHYSICAL INVESTIGATION OF A CONFORMATIONAL DISEASE: ANTITHROMBIN III AALBORG
Pedersen L.	-	TISSUE FACTOR AROUND DERMAL VESSELS HAS BOUND FACTOR VII IN THE ABSENCE OF INJURY
Pedersen T.M.	-	ELEVATED SERUM LEVELS OF LIGHT IN PULMONARY ARTERIAL HYPERTENSION-POTENTIAL INVOLVEMENT IN THROMBUS FORMATION
Pedersen L.	-	VENOUS THROMBOEMBOLISM AND SUBSEQUENT HOSPITALIZATION DUE TO ACUTE CARDIOVASCULAR EVENTS. A 20 YEARS FOLLOW-UP STUDY
Peebles D.	-	MANAGING PERI-DELIVERY ANTICOAGULATION IN WOMEN ON THERAPEUTIC DOSE LOW-MOLECULAR WEIGHT HEPARIN: A ROLE FOR UNFRACTIONATED HEPARIN
	-	SUCCESSFUL MANAGEMENT OF LATE OBSTETRIC COMPLICATIONS IN THE ANTIPHOSPHOLIPID SYNDROME
Peerlinck K.	-	FINAL RESULTS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE PHARMACOKINETICS, EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15 NANOMETER-FILTERED PLASMA-DERIVED FACTOR VIII
	-	ACTIVATION OF HUMAN LUNG ENDOTHELIAL CELLS INDUCES THE RELEASE OF A FVIII STORAGE POOL
Peerschke E.E.I.B.	-	COMPARISON OF PIFA RAPID ASSAY WITH ELISA TO DETECT HEPARIN/PLATELET FACTOR 4 (HPF4) ANTIBODIES
	-	EVALUATION OF A RAPID PARTICLE GEL IMMUNO ASSAY (PAGIA) FOR DETECTION OF HEPARIN/PF4 ANTIBODIES (HPA)
	-	A CHROMOGENIC METHOD FOR QUANTITATION OF DIRECT THROMBIN INHIBITORS: A CASE STUDY
Peeters M.	-	BIOCHEMICAL AND BIOPHYSICAL CHARACTERIZATION OF AN EXTREMELY STABLE TAFI VARIANT
Peetz D.	-	CLINICAL EVALUATION OF A NEW QUANTITATIVE HIGHLY SENSITIVE D-DIMER ASSAY FOR EXCLUSION OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM
	-	THERAPEUTIC DRUG MONITORING OF HEPARINS AND DIRECT THROMBIN INHIBITORS: THE GERMAN EXTERNAL QUALITY ASSESSMENT SCHEME
Pegoraro C.	-	PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME PRESENT A NORMAL ENDOTHELIAL FUNCTION
	-	LOW-INTENSITY (INR TARGET 1,8) VERSUS STANDARD ANTICOAGULATION FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION: A RANDOMIZED SINGLE CENTRE STUDY IN ELDERLY PATIENTS
Pehrsson S.	-	THE ANTITHROMBOTIC EFFECT OF AR-H067637, THE ACTIVE FORM OF THE NOVEL ORAL DIRECT THROMBIN INHIBITOR AZD0837, IN RAT MODELS OF ARTERIAL AND VENOUS THROMBOSIS
Pekun F.	-	RADIOSYNOVECTOMY WITH YTRIUM-90 AND RHENIUM-186 IN HEMOPHILIC ARTHROPATY
Pellecchia D.	-	DETECTION OF LARGE DELETIONS IN HAEMOPHILIA A: CARRIER DETECTION BY MP/LC (MULTIPLEX PCR/LIQUID CHROMATOGRAPHY)
	-	MRNA ANALYSIS IN A SEVERE HAEMOPHILIA A PATIENT: DETECTION OF AN EXON 6 SKIPPING
Pelsers M.M.A.L.	-	HEART-TYPE FATTY ACID BINDING PROTEIN IS PREDICTIVE FOR MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
Peltola K.	-	FRESH FROZEN PLASMA DOES NOT ATTENUATE COAGULATION ACTIVATION AFTER NEONATAL CARDIOPULMONARY BYPASS
Pelzer U.	-	PROSPECTIVE, RANDOMIZED OPEN TRIAL OF ENOXAPARIN IN PATIENTS WITH ADVANCED PANCREATIC CANCER UNDERGOING FIRST-LINE CHEMOTHERAPY
Pelzer H.	-	ANTITHROMBIN (AT) COMPLEX FORMATION IN BEAGLE DOGS AFTER ADMINISTRATION OF A PHARMACOLOGICAL DOSE OF HUMAN RECOMBINANT FACTOR VIIA (RFVIIA)
Pen P.	-	CHANGES OF TISSUE FACTOR PATHWAY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Peña Y.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Peña E.	-	MODIFIED CRP ENHANCES PLATELET ADHESION AND THROMBUS GROWTH ON COLLAGEN
Penaloza A.	-	IS D-DIMER TESTING COST-EFFECTIVE IN ELDERLY PATIENTS CLINICALLY SUSPECTED OF DEEP VEIN THROMBOSIS?
	-	USEFULNESS OF PERFUSION LUNG SCAN COMBINED WITH CLINICAL ASSESSMENT TO RULE OUT PULMONARY EMBOLISM
Pendu R.	-	A MURINE MODEL TO ASSESS VON WILLEBRAND FACTOR FUNCTION IN VIVO
	-	PSGL1 AND LDL-RECEPTORS MEDIATE ADHESION OF LEUKOCYTES TO BETA2-GLYCOPROTEIN-I
Peng J.	-	IDENTIFICATION OF ANERGY-RELATED GENES IN IDIOPATHIC THROMBOCYTOPENIC PURPURA USING MICROARRAY ANALYSIS
	-	TRANSDUCTION OF COLONIC EPITHELIUM IN SEVERE HEMOPHILIA B BY NONINVASIVE APPROACH WITH RAAV2-HFIX RESULTED IN TRANSIENT EXPRESSION
	-	CORRECTION OF TH1 DOMINANT CYTOKINE PROFILES BY HIGH DOSE DEXAMETHASONE IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
Peng H.T.	-	THROMBELASTOGRAPHY STUDY OF HEMOSTATIC AGENTS
Peng B.	-	ANTI-ICOS IMMUNOTHERAPY PREVENTED INHIBITORY ANTIBODY FORMATION AGAINST FACTOR VIII FOLLOWING NONVIRAL GENE TRANSFER IN HEMOPHILIA A MICE
Peng J.	-	PHENOTYPE AND FUNCTION OF CD4+CD25+ REGULATORY T CELLS IN MOUSE MODEL OF EXPERIMENTAL TRANSIENT IMMUNE THROMBOCYTOPENIA AFTER TREATMENT WITH INDIRUBIN
	-	THE CONSTRUCTION OF A HUMANIZED PHAGE ANTIBODY LIBRARY OF ANTI-PLATELET GPIIB/IIIA SINGLE CHAIN FV
Pengo V.	-	EFFECTS OF AGE AND DIFFERENT CUT-OFF VALUES ON USE OF D-DIMER (DD) TESTING TO ESTABLISH DURATION OF ORAL ANTICOAGULATION TREATMENT (OAT) AFTER VENOUS THROMBOEMBOLISM (VTE)
	-	D-DIMER TESTING AND RECURRENT VENOUS THROMBOEMBOLISM AFTER UNPROVOKED PULMONARY EMBOLISM
	-	PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME PRESENT A NORMAL ENDOTHELIAL FUNCTION
	-	DETECTION OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES: THE INFLUENCE OF DIFFERENT ANTIGEN PREPARATIONS
	-	THE MANAGEMENT OF HIGH RISK PREGNANT PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME
	-	THROMBOPHILIA IN PATIENTS WITH CRYPTOGENETIC STROKE AND PATENT FORAMEN OVALE
	-	THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM AFTER DISCONTINUING ANTICOAGULATION IN PATIENTS WITH ACUTE PROXIMAL DEEP VEIN THROMBOSIS OR PULMONARY EMBOLISM. A PROSPECTIVE COHORT STUDY
	-	LOW-INTENSITY (INR TARGET 1,8) VERSUS STANDARD ANTICOAGULATION FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION: A RANDOMIZED SINGLE CENTRE STUDY IN ELDERLY PATIENTS
Pengo M.	-	COMPARISON OF FOUR CLINICAL PREDICTION MODELS IN PATIENTS WITH SUSPECTED PULMONARY EMBOLISM
Pengo V.	-	COMPARISON OF FOUR CLINICAL PREDICTION MODELS IN PATIENTS WITH SUSPECTED PULMONARY EMBOLISM
	-	THE RISK OF FATAL PULMONARY EMBOLISM AFTER STOPPING ANTICOAGULANT THERAPY IN PATIENTS WITH VENOUS THROMBOEMBOLISM
Penka M.	-	THE DIFFERENT SENSITIVITY OF TWO APTT REAGENTS FOR DIAGNOSIS OF LUPUS ANTICOANGULANT
	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
	-	EFFECT OF THE FIRST DOSE SIZE OF RECOMBINANT FACTOR VIIa ON TREATMENT EFFICACY OF FREQUENT JOINT BLEEDS IN PATIENT WITH HAEMOPHILIA A AND INHIBITOR
	-	RFVIIA IS EFFECTIVE ALTERNATIVE TO APCC IN PROPHYLAXIS OF BLEEDING DURING IMMUNE TOLERANCE PROTOCOL IN HAEMOPHILIAC WITH INHIBITOR
	-	ACQUIRED FACTOR VIII INHIBITOR: REPORT FROM THE REGIONAL HAEMOPHILIA CENTRE
Penninger J.	-	DEFICIENCY OF SRC HOMOLOGY 2 DOMAIN-CONTAINING INOSITOL 5-PHOSPHATASE 1 (SHIP1) AFFECTS PLATELET RESPONSES AND THROMBUS GROWTH
Pennings M.T.T.	-	PSGL1 AND LDL-RECEPTORS MEDIATE ADHESION OF LEUKOCYTES TO BETA2-GLYCOPROTEIN-I
Pennings M.T.	-	A DIMER OF B2GLYCOPROTEIN I (B2GPI) UPREGULATES TISSUE FACTOR (TF) AND IS THROMBOGENIC IN VIVO
Pennings M.T.T.	-	ACTIVATION OF PLATELETS BY DIMERIC 2-GLYCOPROTEIN I REQUIRES SIGNALING VIA BOTH GLYCOPROTEIN IBalpha AND APOLIPOPROTEIN E RECEPTOR 2'
	-	DIMERIC 2-GPI BINDS TO LDL-BINDING DOMAIN 1 OF APOER2. PLATELETS EXPRESS THREE 3 DIFFERENT SPLICE VARIANTS OF APOER2 OF WHICH APOER24-5 IS THE MOST ABUNDANT
Pentikäinen O.T.	-	PLATELET INTEGRIN ALPHA2BETA1 INTERACTION WITH TYPE I COLLAGEN IS INHIBITED BY A NOVEL SYNTHETIC MOLECULE BTT-3016
Pentimone F.	-	WHOLE-BLOOD CLOTTING FOR EVALUATING THROMBIN GENERATION IN CHRONIC LIVER FAILURE
Penz S.	-	EFFECT OF ANTI-PLATELET DRUGS ON PLATELET AGGREGATION AND THROMBUS FORMATION INDUCED BY HUMAN ATHEROSCLEROTIC PLAQUES
	-	THE EFFECT OF ADP RECEPTOR ANTAGONISTS AND ASPIRIN ON WHOLE BLOOD PLATELET AGGREGATION MEASURED BY MULTIPLE ELECTRODE AGGREGOMETRY
Pénzes K.	-	MOLECULAR MECHANISM OF INTERACTION BETWEEN ACTIVATED FACTOR XIII AND ITS ACYL DONOR PEPTIDE SUBSTRATE
Peoc'h K.	-	CYP2C19*2 POLYMORPHISM INFLUENCES PLATELET FUNCTIONNALITY IN RESPONSE TO CLOPIDROGEL TREATMENT
	-	ABNORMALITIES IN THE SEROTONIN METABOLISM: A PATHOGENIC HYPOTHESIS FOR CENTRAL RETINAL VEIN OCCLUSION (CRVO)
	-	RESISTANCE TO OAC ASSOCIATED TO A NEW POINT MUTATION IN VKORC1 GENE
Peovska I.	-	ENDOTHELIAL DYSFUNCTION CORRELATES WITH PLASMA FIBRINOGEN AND HDL CHOLESTEROL IN TYPE 2 DIABETIC PATIENTS WITH CORONARY ARTERY DISEASE
Pepe G.	-	MUTATION SCREENING ANALYSIS OF TGFBR1 GENE IN PATIENTS WITH MARFAN SYNDROME
	-	HOMOCYSTINURIA AND CARDIOVASCULAR MANIFESTATIONS: 5 ITALIAN CASES
	-	GENETIC ANALYSIS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS-GAMMA (PPARG) PROMOTERS: ACUTE CORONARY SYNDROME PATIENTS VERSUS CONTROLS
	-	HELICAL COMPUTED TOMOGRAPHY TO ASSESS RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
Peppelenbosch M.P.	-	FACTOR (F)XA STIMULATES FIBROPROLIFERATIVE RESPONSES IN FIBROBLASTS VIA PROTEASE ACTIVATED RECEPTOR (PAR)-2 ACTIVATION: IMPLICATIONS FOR TISSUE REMODELING
	-	COAGULATION FACTOR XA INHIBITS CANCER CELL MIGRATION VIA LIMK1-MEDIATED COFILIN INACTIVATION
Pepper J.F.	-	TWO PATIENTS WITH TYPE III PROTEIN S DEFICIENCY WHO UNDERWENT CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS
Perales P.J.	-	PLASMA INCOAGULABILITY INDUCED BY LONOMIA OBLIQUA BRISTLE EXTRACT IS ASSOCIATED WITH THE ABUNDANT PRESENCE OF LIPOCALINS
Perales M.A.	-	INFLUENCE OF ADDING 4% BSA IN THE BETHESDA ASSAY FOR FACTOR VIII INHIBITOR QUANTIFICATION
Percoco G.	-	TISSUE FACTOR AND COAGULATION FACTOR VII LEVELS DURING ACUTE MYOCARDIAL INFARCTION CONTRIBUTE TO PREDICT MORTALITY AND RE-INFARCTION
Perederyaeva E.B.	-	INHERITED AND ACQUIRED THROMBOPHILIA IN PATIENTS WITH METABOLIC SYNDROME IN OBSTETRIC-GYNECOLOGIC PRACTICE
Pereira M.	-	SCREENING FOR THROMBOPHILIA: RETROSPECTIVE STUDY IN WOMEN WITH GESTACIONAL VASCULAR COMPLICATIONS
Pereira J.	-	PLASMA LEVELS OF CLOTTING FACTORS ARE POSITIVELY CORRELATED IN HEALTHY POPULATION: A COMPREHENSIVE PERSPECTIVE TO ASSESS THROMBOTIC RISK?
Pereira M.	-	MASSIVE VENOUS THROMBOEMBOLISM IN A PEDIATRIC PATIENT: A CASE REPORT
Pereira G.A.G.	-	ANALYSIS OF THE GENETIC EXPRESSION OF INFLAMMATORY MEDIATORS IN MONONUCLEAR CELLS FROM DEEP VENOUS THROMBOSIS PATIENTS
Pereira R.	-	PROTHROMBIN COMPLEX CONCENTRATE FOR REVERSAL OF ORAL ANTICOAGULATION THERAPY IN URGENT SITUATIONS. EXPERIENCE OF A SINGLE CENTER
Pereira J.	-	TISSUE FACTOR-DEPENDENT COAGULANT ACTIVITY OF PLATELET-MONOCYTE COMPLEXES IN CHRONIC RENAL FAILURE (CRF). ASSOCIATION WITH HEMOSTATIC ACTIVITY, INFLAMMATION, OXIDATIVE DAMAGE AND ENDOTHELIAL DYSFUNCTION
Pereira F.G.	-	ANALYSIS OF MICROPARTICLES IN DEEP VENOUS THROMBOSIS AND ANTIPHOSPHOLIPID SYNDROME PATIENTS AND CARRIERS OF LEIDEN FACTOR V
Pereira J.	-	TRANEXAMIC ACID DELAYS THE CLOT LYSIS TIME, AND INCREASES THE ENDOGENOUS THROMBIN GENERATION AND PLASMA PROCARBOXYPEPTIDASE U (TAFI) LEVELS IN PATIENTS WITH MUCOCUTANEOUS BLEEDING
	-	PLASMA PROCPU (TAFI) AND CLOT LYSIS TIME ARE CORRELATED WITH CLOTTING FACTOR LEVELS AND THROMBIN GENERATION: A NOVEL APPROACH TO ASSESS THROMBOSIS RISK?
	-	INDUCTION OF TISSUE FACTOR ACTIVITY IN STIMULATED PLATELETS
Pereira C.	-	TRANSCRIPTOME ANALYSIS OF THE PAR-1 MEDIATED ACTIVATION PATHWAY IN HUMAN MONOCYTES AND INTERACTIONS OF ACTIVATED PROTEIN C
Pereira A.	-	ATS-13 ACTIVITY AS A COMMON MARKER OF THE ENDOTHELIAL DYSFUNCTION DEVELOPING IN THROMBOTIC MICROANGIOPATHIES OF DIFFERENT ORIGIN
Perés Wingeyer S.	-	4G/5G POLYMORPHISM IN THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN OBESE HISPANIC ADULTS
Perez N.F.	-	HANDHELD COMPUTERS: AN EFFECTIVE SYSTEM TO RECORD HOME-THERAPY DATA OF PATIENTS WITH HAEMOPHILIA
Perez J.	-	PROGNOSTIC FACTORS OF SHORT-TERM SURVIVAL IN PATIENTS WITH DEEP VEIN THROMBOSIS: FINDINGS FROM A PROSPECTIVE REGISTRY (RIETE)
Perez Y.	-	BIOEQUIPOTENCY OF IDRAPARINUX AND BIOTINYLATED IDRAPARINUX AFTER SINGLE DOSE IN HEALTHY SUBJECTS
	-	NEUTRALIZATION BY AVIDIN OF ANTICOAGULANT ACTIVITY OF BIOTINYLATED IDRAPARINUX, THE FIRST AND UNIQUE REVERSIBLE LONG-ACTING ANTICOAGULANT
Perez J.	-	D-DIMER LEVELS CORRELATE WITH MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM: FINDINGS FROM THE RIETE REGISTRY
Perez R.	-	MILD HAEMOPHILIA A (P. A1824T) ASSOCIATED WITH HEREDITARY COAGULATION FACTOR XII DEFICIENCY AND HETEROZYGOUS PROTHROMBIN 20210G/A MUTATION
Perez de Pedro I.	-	ACQUIRED HEMOPHILIA IN AN HIV PATIENT
Perez Garrido R.	-	HANDHELD COMPUTERS: AN EFFECTIVE SYSTEM TO RECORD HOME-THERAPY DATA OF PATIENTS WITH HAEMOPHILIA
Perez Lloret S.	-	FACTOR V IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CIRRHOSIS: USEFUL TOOL IN PATIENTS WAITING FOR LIVER TRANSPLANTATION
Perez Rus G.	-	HEPARIN-INDUCED THROMBOCYTOPENIA IN A PATIENT WITH POLYCYTEMIA VERA: A THREATENING ASSOCIATION
Perez-Casal M.	-	CYTOPROTECTION AND ANTICOAGULATION BY ACTIVATED PROTEIN C ON CIRCULATING MICROPARTICLE-ASSOCIATED ENDOTHELIAL PROTEIN C RECEPTOR
Pérez-Ceballos E.	-	FLAVONOIDS INHIBIT PLATELET ADHESION AND AGGREGATION UNDER FLOW: BLOCKADE OF TXA2 RECEPTORS IN PLATELET RICH PLASMA
	-	ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
Pérez-Montes R.	-	RITUXIMAB TREATMENT FOR MILD HEMOPHILIA A WITH INHIBITORS
Perez-Pujol S.	-	INK4A/ARF DEFICIENT MICE HAVE A DEFICIENT PLATELET FUNCTION
Pergantou H.	-	MORE THAN ONE EPISODES IN CHILDHOOD ITP WITH A MEDIASTINUM OF MONTHS OR YEARS. A 30 YEARS RETROSPECTIVE ANALYSIS
Perkmann T.	-	REGULATION OF PROTEIN C INHIBITOR (PCI) ACTIVITY BY OXIDIZED AND NEGATIVELY CHARGED PHOSPHOLIPIDS
	-	THROMBOGENICITY OF MICROPARTICLES DERIVED FROM VASCULAR CELLS
Permin L.	-	EVALUATION OF THROMBOELASTOGRAPHY (TEG) ASSAYS FOR MONITORING EX VIVO EFFECT OF RFVIIA (NOVOSEVEN) IN HAEMOPHILIA A AND B PATIENTS
Perneby C.	-	EFFECT OF CLOPIDOGREL TREATMENT ON STRESS-INDUCED PLATELET ACTIVATION AND MYOCARDIAL ISCHEMIA IN ASPIRIN-TREATED PATIENTS WITH STABLE CORONARY ARTERY DISEASE
Pernod G.	-	TAFI ACTIVITY LEVELS AND RECURRENT VENOUS THROMBOEMBOLIC DISEASE
	-	RISK FACTORS PREDICTIVE OF CARDIOVASCULAR EVENTS IN AN INCIDENT DIALYSIS COHORT: A ROLE FOR HOMOCYSTEINEMIA AND ITS MTHFR GENOTYPE
	-	CLINICAL RISK FACTORS AND 3 MONTHS OUTCOMES OF SYMPTOMATIC CALF VEIN THROMBOSIS: FINDINGS FROM THE OPTIMEV COHORT
	-	IS THROMBO-EMBOLIC DISEASE AN HETEROGENEOUS DISEASE ?
Pernow J.	-	NO EFFECT OF LIPID LOWERING BY SIMVASTATIN OR SIMVASTATIN AND EZETIMIBE ON PLATELET FUNCTION IN PATIENTS WITH TYPE 2 DIABETES OR IMPAIRED GLUCOSE TOLERANCE AND CORONARY ARTERY DISEASE
Perrault C.	-	A NEW LEU123 TO PRO MUTATION IN THE FIFTH LEUCINE-RICH REPEAT OF GLYCOPROTEIN IBALPHA IN A BERNARD-SOULIER PATIENT INDUCES DEFECTIVE SHEAR-DEPENDENT CELL ADHESION ON VON WILLEBRAND FACTOR
Perret-Guillaume C.	-	SIGNIFICANCE OF PLASMA SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR AND TISSUE FACTOR PATHWAY INHIBITOR IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
Perri L.	-	OXIDATIVE STRESS-MEDIATED PLATELET CD40 LIGAND UPREGULATION IN PATIENTS WITH HYPERCHOLESTEROLEMIA. EFFECT OF ATORVASTATIN
Perrier A.	-	INFLUENCE OF AGE ON THE COST EFFECTIVENESS OF DIAGNOSTIC STRATEGIES FOR SUSPECTED PULMONARY EMBOLISM
	-	A DECISION SUPPORT TOOL ON HANDELD COMPUTERS TO IMPROVE DIAGNOSTIC STRATEGIES OF PULMONARY EMBOLISM IN EMERGENCY DEPARTMENTS (SPEED STUDY)
	-	USEFULNESS OF MULTIDETECTOR COMPUTED TOMOGRAPHY IN PATIENTS WITH SYMPTOMS SUGGESTING PULMONARY EMBOLISM
	-	MULTI-DETECTOR SPIRAL COMPUTED TOMOGRAPHY ALONE VERSUS COMBINED WITH LOWER LIMB COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF PULMONARY EMBOLISM: A RANDOMISED NON-INFERIORITY TRIAL
	-	PULMONARY EMBOLISM FAILURE RATE IN PATIENTS IN WHOM PULMONARY EMBOLISM WAS RULED OUT BY LOW AND INTERMEDIATE PROBABILITY BY THE REVISED GENEVA SCORE AND A NORMAL QUANTITATIVE D-DIMER TEST RESULT
	-	COMPARISON OF THE REVISED GENEVA RULE WITH WELLS RULE FOR ASSESSING CLINICAL PROBABILITY OF PULMONARY EMBOLISM
Perry D.J.	-	THE UK NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME (UK NEQAS) FOR MOLECULAR GENETIC TESTING IN HAEMOPHILIA
Perry C.	-	THE EFFECT OF ABO BLOOD GROUP ON VON WILLEBRAND FACTOR PROPEPTIDE LEVELS IN NORMAL INDIVIDUALS
Pershikov S.V.	-	CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION
Persichillo M.	-	FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY
	-	ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
	-	ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS
	-	ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
Person T.	-	ABNORMAL PLATELET FUNCTION IS COMMON IN PEDIATRIC CONGENITAL CARDIAC SURGERY PATIENTS
Persson E.	-	MAGNESIUM IONS BIND TO THE FACTOR X (FX) GLA DOMAIN AND PROMOTE FX ACTIVATION BY FACTOR VIIA BOUND TO SOLUBLE TISSUE FACTOR (TF) BUT ACT INHIBITORY WHEN BOUND TO LIPIDATED TF
	-	ACTIVATION LOOP 3 AND THE 170 LOOP INTERACT IN THE MOST ACTIVE CONFORMATION OF FACTOR VIIA
	-	PROBING THE ORIGINS OF ACTIVITY ENHANCEMENT IN FACTOR VIIA (FVIIA) VARIANTS BY HYDROGEN EXCHANGE MASS SPECTROMETRY (HX-MS)
Pertuiset N.	-	IMMUNE TOLERANCE IN AN ADULT AFTER A LONG TERM HISTORY OF I,HIBITOR
Perucchetti Y.	-	ANTI-BETA 2 GLYCOPROTEIN I ANTIBODIES ASSAYS: USE OF MONOCLONAL ANTIBODIES FOR CALIBRATION
Perunicic J.	-	INVESTIGATION OF ACQUIRED VON WILLEBRAND'S SYNDROME IN PATIENTS WITH HYPOTHYROIDISM
Perzborn E.	-	RECOMBINANT FACTOR VIIA PARTIALLY REVERSES THE ANTICOAGULANT EFFECT OF HIGH-DOSE RIVAROXABAN A NOVEL, ORAL, DIRECT FACTOR XA INHIBITOR IN RATS
	-	RECOMBINANT FACTOR VIIA PARTIALLY REVERSES THE EFFECTS OF THE FACTOR XA INHIBITOR RIVAROXABAN ON THROMBIN GENERATION, BUT NOT THE EFFECTS OF THROMBIN INHIBITORS, IN VITRO
	-	COMBINING RIVAROXABAN WITH ACETYLSALICYLIC ACID INCREASES ANTITHROMBOTIC POTENCY WITHOUT AFFECTING BLEEDING TIMES IN ANIMAL MODELS
	-	RIVAROXABAN A NOVEL, ORAL, DIRECT FACTOR XA INHIBITOR ENHANCED THE ANTITHROMBOTIC EFFECTS OF CLOPIDOGREL IN RATS
	-	RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR INHIBITS TISSUE FACTOR-MEDIATED PLATELET AGGREGATION
	-	AN IN VIVO RISK/BENEFIT COMPARISON OF THE EFFECTS OF RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR WITH THROMBIN INHIBITORS, WARFARIN AND CLOPIDOGREL
Pesavento R.	-	PREVENTION OF RECURRENT THROMBOEMBOLISM BY ADJUSTING THE DURATION OF ANTICOAGULATION ACCORDING TO RESIDUAL VEIN THROMBOSIS. A RANDOMIZED STUDY
	-	THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM AFTER DISCONTINUING ANTICOAGULATION IN PATIENTS WITH ACUTE PROXIMAL DEEP VEIN THROMBOSIS OR PULMONARY EMBOLISM. A PROSPECTIVE COHORT STUDY
	-	D-DIMER AS AN ADJUNCT TO COMPRESSION ULTRASONOGRAPHY IN PATIENTS WITH SUSPECTED RECURRENT IPSILATERAL DEEP VEIN THROMBOSIS. A PROSPECTIVE COHORT STUDY
	-	METABOLIC SYNDROME AND HYPERHOMOCYSTEINEMIA IN PATIENTS WITH DEEP VEIN THROMBOSIS: A CASE-CONTROL STUDY
	-	QUALITY OF ORAL ANTICOAGULANT TREATMENT AND RISK OF SUBSEQUENT RECURRENT THROMBOEMBOLISM IN PATIENTS WITH DEEP VENOUS THROMBOSIS. A PROSPECTIVE COHORT STUDY
Pesch M.	-	INCREASED PLASMINOGEN ACTIVITY IS AN INDEPENDENT PREDICTOR OF BLEEDING IN HEMOPHILIACS
Pescott M.A.	-	ACCEPTABILITY AND EFFICACY OF PATIENT SELF-TESTING IN PATIENTS NEW TO THE ANTICOAGULATION CLINIC
Pessoa P.C.H.	-	MANAGING SUSPECTED VENOUS THROMBOEMBOLISM IN A MIXED PRIMARY AND SECONDARY CARE SETTING USING STANDARD CLINICAL ASSESSMENT AND D-DIMER IN A NON-INVASIVE DIAGNOSTIC STRATEGY
Petäjä J.	-	FRESH FROZEN PLASMA DOES NOT ATTENUATE COAGULATION ACTIVATION AFTER NEONATAL CARDIOPULMONARY BYPASS
Petakov M.	-	INVESTIGATION OF ACQUIRED VON WILLEBRAND'S SYNDROME IN PATIENTS WITH HYPOTHYROIDISM
Peter K.	-	CONFORMATION-SPECIFIC BLOCKADE OF THE INTEGRIN GPIIB/IIIA): IN VITRO AND IN VIVO RESULTS DEMONSTRATING A SELECTIVE PLATELET BLOCKADE WITH LESS ADVERSE EFFECTS
	-	A NOVEL SINGLE-CHAIN (SCFV) ANTIBODY PHAGE-DISPLAY STRATEGY FOR THE DEVELOPMENT OF POTENTIAL ANTI-ATHEROSCLEROTIC DRUGS
	-	MECHANISM OF PARADOXICAL PLATELET ACTIVATION INDUCED BY GPIIB/IIIA ANTAGONISTS
	-	EVIDENCE FOR AN ALTERNATIVE REGULATION OF THE ACTIVITY OF THE BETA3-INTEGRIN ALPHAVBETA3 IN THE ABSENCE OF THE HIGHLY CONSERVED ALPHA-SUBUNIT GFFKR MOTIF
Peternel P.	-	ENDOTHELIAL FUNCTION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND HISTORY OF VENOUS THROMBOSIS
	-	OVERALL HAEMOSTASIS POTENTIAL IN PATIENTS WITH VENOUS THROMBOSIS BEFORE, DURING AND AFTER ANTICOAGULANT TREATMENT
Peters M.	-	VENOUS THROMBOSIS AND THE POST THROMBOTIC SYNDROME AFTER FEMORAL CATHETERIZATION
Peters R.T.	-	ENHANCED PHARMACOKINETICS OF FACTOR IX AS A MONOMERIC FC FUSION
Peters R.	-	BENEFIT-RISK RATIO OF FONDAPARINUX IN DIABETIC PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION (STEMI): A SUBANALYSIS OF OASIS-6
	-	MORTALITY BENEFIT OF FONDAPARINUX VERSUS ENOXAPARIN IN DIABETIC PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES (NSTE-ACS): A SUBANALYSIS OF OASIS-5
Peters G.	-	ACTIVATED PLATELETS ENHANCE THE ADHERENCE TO AND INVASION OF ENDOTHELIAL CELLS BY STAPHYLOCOCCUS AUREUS
Peters M.	-	OVERWEIGHT IN DUTCH HAEMOPHILIA PATIENTS
Petersen L.	-	ANTITHROMBIN (AT) COMPLEX FORMATION IN BEAGLE DOGS AFTER ADMINISTRATION OF A PHARMACOLOGICAL DOSE OF HUMAN RECOMBINANT FACTOR VIIA (RFVIIA)
Petersen L.C.	-	CLEARANCE OF FACTOR VIIA (FVIIA) IN THE MOUSE IS NOT AFFECTED BY ALPHA 2-MACROGLOBULIN GENE DELETION OR ACTIVE-SITE BLOCKAGE OF FVIIA
Petersen H.	-	UNFRACTIONATED HEPARIN (UFH) OR LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AS PERIOPERATIVE BRIDGING THERAPY IN PATIENTS WITH MECHANICAL HEART VALVES (MHVS) ON LONG-TERM ORAL ANTICOAGULANTS (OAC): RESULTS FROM THE REGIMEN REGISTRY
Petersen L.C.	-	EFFECT OF FACTOR XIII ON THE ANTI-FIBRINOLYTIC ACTIVITY OF THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI)
	-	COAGULATION FACTOR VIIA VARIANTS WITH REDUCED SUSCEPTIBILITY TO INHIBITION BY ANTITHROMBIN III
Petersen J.M.	-	IMPROVING THE PHARMACOKINETICS OF RECOMBINANT FACTOR VIIA CYS407 BY CYSTEINE-DIRECTED PEGYLATION
Petersen L.C.	-	COMBINED EFFECTS OF RFVIIA AND RFXIII ON CLOT FORMATION AND STABILITY IN PLASMA AND BLOOD FROM NORMAL DONORS AND FROM THROMBOCYTOPENIC PATIENTS
Peterson J.A.	-	RARE ANTIGENS IN NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
Petitjean C.	-	ABNORMAL MEGAKARYOCYTE MATURATION WITH IMPAIRED PROPLATELET FORMATION IN A MOUSE MODEL OF BERNARD-SOULIER SYNDROME
Petitou M.	-	REVERSIBLE BIOTINYLATED OLIGOSACCHARIDES: A NEW APPROACH FOR A BETTER MANAGEMENT OF THE ANTICOAGULANT THERAPY
	-	ANTITHROMBOTIC ACTIVITIES IN PHARMACOLOGICAL MODELS OF A LONG-ACTING REVERSIBLE SYNTHETIC OLIGOSACCHARIDE
	-	IN VITRO AND EX VIVO PROPERTIES OF LONG-ACTING REVERSIBLE OLIGOSACCHARIDES
	-	SULFATION OF THE 3-HYDROXYL GROUP OF THE REDUCING UNIT (H) ON ALKYLATED SULFATED PENTASACCHARIDE IS RESPONSIBLE FOR A HIGH AFFINITY FOR ANTITHROMBIN AND LONGER HALF LIFE IN ANIMALS
	-	SYNTHESIS AND PROPERTIES OF BIOTINYLATED ANTITHROMBOTIC OLIGOSACCHARIDES
Petralia G.A.	-	VENOUS THROMBOEMBOLISM AND CANCER: THE PERCEIVE REGISTRY
Petrini P.	-	LONG-TERM PHARMACOVIGILANCE UPDATE WITH A RECOMBINANT FVIII CONCENTRATE FOR THE TREATMENT OF HEMOPHILIA A
Petropoulou A.D.	-	HYPERCOAGULABLE STATE IN MULTIPLE MYELOMA PATIENTS TREATED OR NOT WITH THALIDOMIDE
	-	ENDOTHELIAL IMPACT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Petros S.	-	MONITORING NOVOSEVEN THERAPY WITH DIFFERENT METHODS
	-	INHIBITOR AGAINST F V MONTORING WITH THROMBIN GENERATION ASSAYS
Petrov V.J.	-	IDIOPATHIC THROMBOCYTOPENIC PURPURA AND OPPORTUNISTIC INFECTIONS IN CHILDREN
	-	LEVEL OF PLASMA GLYCOCALICIN IN CHILDREN WITH THROMBOCYTOPENIA
Petrov M.	-	ENOXAPARIN VERSUS HEPARIN PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM AFTER ABDOMINAL ONCOLOGIC SURGERY: A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL
Petrovan R.J.	-	FLK-1-BASED DNA VACCINATION REDUCES ATHEROSCLEROTIC LESION GROWTH IN HYPERLIPIDEMIC MICE
Petrus I.	-	RESTORATION OF VON WILLEBRAND FACTOR FUNCTION IN A MURINE MODEL OF SEVERE VON WILLEBRAND DISEASE AFTER LIVER SPECIFIC GENE TRANSFER
Petterson T.M.	-	IMPACT OF VENOUS THROMBOEMBOLISM, VENOUS STASIS SYNDROME, VENOUS OUTFLOW OBSTRUCTION AND VENOUS VALVULAR INCOMPETENCE ON QUALITY OF LIFE AND ACTIVITIES OF DAILY LIVING: A POPULATION-BASED CASE-CONTROL STUDY
	-	RISK FACTORS FOR VENOUS THROMBOEMBOLISM (VTE) AMONG ACTIVE CANCER PATIENTS: A POPULATION-BASED CASE-CONTROL STUDY
Petteway S.	-	IMPORTANCE OF FIBRIN BINDING FOR THERAPEUTIC EFFICACY OF DIRECT THROMBOLYTICS
Pettinella C.	-	ASSOCIATION BETWEEN ENHANCED SOLUBLE CD40 LIGAND AND PLATELET ACTIVATION IN HYPERTENSIVES WITH MICROALBUMINURIA
Peyrafitte M.	-	MICROPARTICLES PROCOAGULANT ACTIVITY IN CITRATED PLASMA
	-	CLASSIFICATION OF FACTOR V-LEIDEN CARRIERS BY QUANTITATIVELY MEASURING ITS PROCOAGULANT ACTIVITY COMPARATIVELY TO THAT OF FACTOR V
	-	QUANTITATIVE MEASUREMENT OF FACTOR V-LEIDEN WITH A NEW ONE STEP, CALIBRATED, CLOTTING METHOD
	-	NEW APPROACH FOR DETECTION OF HEPARIN DEPENDENT ANTIBODIES AND RISK ASSESSMENT FOR HEPARIN INDUCED THROMBOCYTOPENIA
Peyrard S.	-	LACK OF ENDOTHELIAL DYSFUNCTION IN THROMBOANGIITIS OBLITERANS
Peyrezabes E.	-	EVALUATION OF IN-VITRO STABILITY AND MICROBIOLOGICAL SAFETY OF RECONSTITUTED VON WILLEBRAND FACTOR CONCENTRATE
Peyvandi F.	-	PLATELET ADAMTS13 AND IN VITRO EXPRESSION STUDY OF A PATIENT AFFECTED BY CONGENITAL TTP
	-	ALTERNATIVE SPLICING AND NONSENSE-MEDIATED DECAY IN THE F5 GENE
	-	GYNAECOLOGICAL AND OBSTETRICAL PROBLEMS IN WOMEN AFFECTED WITH INHERITED BLEEDING DISORDERS
	-	MUTATIONS IN THE MCFD2 GENE ARE PREDOMINANT AMONG PATIENTS WITH HEREDITARY COMBINED FACTOR V AND FACTOR VIII DEFICIENCY (F5F8D) IN INDIA
	-	WHAT DO WE EXPECT FROM THE INTERNATIONAL REGISTRY?
	-	EFFECT OF PH AND TEMPERATURE ON ADAMTS-13 CATALYSIS
	-	MECHANISMS COUPLING PROTEIN FOLDING AND TRANSPORT AT THE ER-GOLGI INTERFACE: ROLE IN F5F8D AND OTHER DISEASES
	-	A MULTICENTRE PROSPECTIVE OPEN-LABEL STUDY ASSESSING PHARMACOKINETICS, CLINICAL EFFICACY AND SAFETY OF A TRIPLE-SECURED FIBRINOGEN CONCENTRATE: FIBRINOGENE T-I
	-	DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
	-	DETERMINATION OF ANTI-ADAMTS13 AUTOANTIBODIES IN THROMBOTIC TROMBOCITOPENIC PURPURA (TTP) PATIENTS: COMPARISON OF TWO DIFFERENT METHODS
	-	GYNAECOLOGICAL BLEEDING IN CONGENITAL FACTOR VII DEFICIENCY
	-	NEW INSIGHTS IN ADAMTS13 PHYSIOLOGY BY MEASURING ACTIVITY OVER ANTIGEN RATIO
	-	MISSENSE MUTATIONS IN THE COILED-COIL REGION OF FIBRINOGEN AALPHA CHAIN CAUSE FIBRINOGEN DEFICIENCY BY IMPAIRING DIMERIZATION OF TRIMERIC INTERMEDIATES
	-	KINETICS STUDIES OF A NATURALLY OCCURRING MUTATION ON FACTOR X (FX) GENE (G222D)
	-	GENETIC CHARACTERIZATION OF PATIENTS WITH BERNARD-SOULIER SYNDROME AND THEIR RELATIVES FROM SOUTHERN IRAN
Pezzullo S.	-	RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM
Pfirsch S.	-	COORDINATED ACTION OF GPVI AND FCRGAMMA CYTOPLASMIC DOMAINS IN SIGNALLING
Pfister M.	-	EXPOSURE-CLINICAL OUTCOME MODELING AND SIMULATION TO FACILITATE DOSE SELECTION OF APIXABAN IN SUBJECTS UNDERGOING ELECTIVE TOTAL KNEE REPLACEMENT SURGERY
Pfrang J.	-	INCREASED EXPRESSION OF AND ENHANCED PLATELET REACTIVITY TO FRACTALKINE IN TYPE-II DIABETIC ZDF-RATS
Pham H.	-	ADDITION OF PRION REDUCTION FACTORS FROM SINGLE STEP EXPERIMENTS MAY OVERESTIMATE MANUFACTURING PROCESS CLEARANCE CAPABILITY
Pham M.	-	INHIBITION OF GPIB, BUT NOT GPIIB/IIIA, IMPROVES EXPERIMENTAL STROKE OUTCOME WITHOUT BLEEDING COMPLICATIONS
Pham H.	-	THE STABILITY OF A PLASMA-DERIVED FACTOR VIII PRODUCT DURING SIMULATED CONTINUOUS INFUSION
Phayphet M.	-	RENAL IMPAIRMENT ESTIMATES TO PREDICT THE HAEMORRHAGE RISK IN 2170 PATIENTS TREATED BY HEPARIN. COCKCROFT-GAULT OR SIMPLIFIED MDRD?
Philipp C.S.	-	LABORATORY CHARACTERISTICS OF WOMEN WITH MENORRHAGIA: A MULTI-SITE U.S. STUDY
	-	QUALITY OF LIFE (QOL) EVALUATION IN WOMEN WITH MENORRHAGIA AND ABNORMAL HEMOSTASIS TESTING PARTICIPATING IN A CROSS-OVER STUDY OF INTRANASAL DESMOPRESSIN AND ORAL TRANEXAMIC ACID
Philipp K.	-	ENDOGENOUS THROMBIN POTENTIAL IN PREGNANT WOMEN RECEIVING LOW MOLECULAR WEIGHT HEPARIN (LMWH)
Philipp C.S.	-	THE EFFECT OF INTRANASAL DESMOPRESSIN VS. ORAL TRANEXAMIC ACID ON MENSTRUAL BLOOD LOSS AMONG WOMEN WITH MENORRHAGIA AND ABNORMAL LABORATORY HEMOSTASIS: A MULTICENTER, RANDOMIZED CROSS-OVER STUDY
Philippou H.	-	PROTEOLYTIC CLEAVAGE OF ACTIVATED COAGULATION FACTOR XIII BY PLASMIN: NOVEL MECHANISM OF FACTOR XIII REGULATION?
	-	MULTIPLE SITES OF FXIIIA ARE INVOLVED IN THE BINDING INTERACTION TO THE ALPHA CHAIN OF FIBRINOGEN
	-	THE LOCALISATION OF A NOVEL FACTOR XIIIB BINDING SITE ON THE ALPHA CHAIN OF FIBRINOGEN AND ITS ROLE IN FXIII DISSOCIATION
	-	IDENTIFICATION OF PROTEOLYTIC CLEAVAGE
Phillips D.R.	-	DIFFERENTIAL EFFECTS OF ANTI-PLATELET DRUGS ON THROMBUS FORMATION AND THROMBUS STABILITY
	-	PRT060128, A NOVEL, DIRECT-ACTING ORALLY AVAILABLE P2Y12 ANTAGONIST, CONFERS SUPERIOR ANTITHROMBOTIC ACTIVITY OVER CLOPIDOGREL IN A MOUSE THROMBOSIS MODEL
	-	INITIAL INTRAVENOUS EXPERIENCE WITH PRT060128 (PRT128), AN ORALLY-AVAILABLE, DIRECT-ACTING, AND REVERSIBLE P2Y12 INHIBITOR
Phillips L.E.	-	THE HAEMOSTASIS REGISTRY AUSTRALIAN AND NEW ZEALAND EXPERIENCE WITH RFVIIA
Phillips D.R.	-	MEASUREMENT OF THROMBUS STABILITY PREDICTS CORONARY EVENTS POST-PERCUTANEOUS CORONARY INTERVENTION (PCI)
	-	ANTAGONISM OF INTRINSIC PATHWAY INHIBITS TISSUE FACTOR (TF)-INITIATED COAGULATION IN A PLATELET-DEPENDENT WHOLE BLOOD FLOW ASSAY
Phoenix F.	-	RECOMBINANT BBETA-LYS448 IS ASSOCIATED WITH SIGNIFICANT CHANGES IN FIBRIN STRUCTURE AND CLOT RIGIDITY
Piano S.	-	THROMBOCYTOPENIA AND CONGENITAL RADIAL DYSPLASIA: A CONTINUUM SPECTRUM OF DISEASES. CASE REPORT
Piazzón I.	-	EVALUATION OF VON WILLEBRAND FACTOR IN A MURINE MODEL UNDER STEROID HORMONE TREATMENT
Piccioli A.	-	LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY
Piccoli A.	-	ANTI-INFLAMMATORY EFFECS OF CLOPIDOGREL IN THE MOUSE
	-	PHOSPHODIESTERASE-TYPE IV REGULATES PMN/PLATELET INTERACTION IN VITRO AND PMN ACCUMULATION AT THE SITE OF VASCULAR INJURY IN VIVO
Pickering W.M.	-	THE EFFECT OF ACTIVATED FACTOR IX ON THE FACTOR IX COAGULANT AND NAPTT ACTIVITY OF A HIGH-PURITY FACTOR IX CONCENTRATE
Piepenbrock S.	-	AN EX VIVO PERFUSION MODEL TO STUDY THE TREATMENT OF THROMBOTIC MICROANGIOPATHY DURING PIG-TO-HUMAN XENOGENIC KIDNEY TRANSPLANTATION
	-	EFFECTS OF FIBRINOGEN LEVELS AND CLOT STRENGTH IN THE PRESENCE OF THROMBOCYTOPENIA
Pieragnoli P.	-	CHANGES OF INFLAMMATORY MARKERS DURING FOLLOW-UP OF PATIENTS WITH HEART FAILURE UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
Pierangeli S.S.	-	A DIMER OF B2GLYCOPROTEIN I (B2GPI) UPREGULATES TISSUE FACTOR (TF) AND IS THROMBOGENIC IN VIVO
	-	EFFECTS OF AN INHIBITOR OF NUCLEAR FACTOR-KAPPA B (NF-KB) ON THROMBOGENIC PROPERTIES OF ANTIPHOSPHOLIPID ANTIBODIES IN VIVO
	-	ROLE OF P38 MITOGEN ACTIVATED PROTEIN KINASE IN ANTIPHOSPHOLIPID ANTIBODY-MEDIATED THROMBOSIS AND ENDOTHELIAL CELL ACTIVATION
	-	EFFECTS OF A TOLL-LIKE RECEPTOR ANTAGONIST AND ANTI-ANNEXIN A2 ANTIBODIES ON BINDING AND ACTIVATION OF DECIDUAL CELLS BY ANTIBETA2GLYCOPROTEIN I ANTIBODIES
	-	THE TRANSCRIPTION FACTOR EGR-1 PLAYS A CRITICAL ROLE IN ANTIPHOSPHOLIPID ANTIBODY-MEDIATED THROMBOSIS
	-	EFFECTS OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FROM APL PATIENTS WITH APS OR WITH LEPROSY IN AN IN VIVO MODEL OF APS
Pierce G.	-	SITE-SPECIFIC PEGYLATION OF RFVIII RESULTS IN PROLONGED IN VIVO EFFICACY
Pierce G.F.	-	EVALUATION OF PEG-FVIII MOLECULES WITH PROLONGED HALF-LIVES IN A MURINE FVIII-DEPENDENT BLEEDING MODEL
Pieresca C.	-	PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
Pieroni G.	-	POST-INFECTIOUS PURPURA FULMINANS (PF): 12 YEAR-EXPERIENCE AT A SINGLE ARGENTINEAN CENTER
	-	USE OF RECOMBINANT ACTIVATED FACTOR VII IN NON-HEMOPHILIC CHILDREN
	-	TYPE 2B VON WILLEBRAND'S DISEASE. REPORT FROM A SINGLE CENTER IN ARGENTINA
Pieters R.	-	AGE-RELATED CHANGES BY ASPARAGINASE ON COAGULATION AND FIBRINOLYSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Pieters H.	-	CORONARY ARTERY IN-STENT STENOSIS PERSISTS DESPITE INHIBITION OF THE VON WILLEBRAND FACTOR-COLLAGEN INTERACTION IN BABOONS
Pieters M.	-	THE EFFECT OF FIBRINOGEN GLYCATION ON FIBRIN NETWORK STRUCTURE OF TYPE II DIABETIC SUBJECTS
	-	THE EFFECT OF FIBRINOGEN GLYCATION ON FIBRIN NETWORK STRUCTURE OF TYPE II DIABETIC SUBJECTS
Pietrini P.	-	WHOLE-BLOOD CLOTTING FOR EVALUATING THROMBIN GENERATION IN CHRONIC LIVER FAILURE
Pietrobon F.	-	UPDATE OF THE ITALIAN HAEMOPHILIA B MUTATION DATABASE
	-	PRENATAL DIAGNOSIS OF HAEMOPHILIA A BY USING INTRON 1 INVERSION MUTATION
Pietz B.C.	-	CORRELATIONS BETWEEN ADAMTS13 ACTIVITY AND INHIBITOR LEVELS: OBSERVATIONS AND IMPLICATIONS FOR RESOURCE UTILIZATION
	-	RARE ANTIGENS IN NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
Pignatelli P.	-	LDL-CHOLESTEROL ENHANCES PLATELET RECRUITMENT VIA GP91PHOX-MEDIATED CD40L UPREGULATION
	-	EARLY INCREASE OF OXIDATIVE STRESS AND SOLUBLE CD40L IN CHILDREN
	-	LDL ARE OXIDATIVELY MODIFIED BY PLATELETS VIA GP91PHOX
	-	OXIDATIVE STRESS-MEDIATED PLATELET CD40 LIGAND UPREGULATION IN PATIENTS WITH HYPERCHOLESTEROLEMIA. EFFECT OF ATORVASTATIN
Pignatti P.F.	-	INCREASED ARACHIDONIC/LINOLEIC RATIO AND A POLYGENIC MODEL OF DESATURASE POLYMORPHIMS ARE ASSOCIATED WITH INCREASED RISK OF CORONARY ARTERY DISEASE
Pignieri A.	-	PAR-1 AND PAR-2 ACTIVATION MEDIATES TISSUE FACTOR INDUCTION IN ENDOTHELIAL CELLS THROUGH A REDOX-SENSITIVE SIGNALING PATHWAY
	-	TISSUE FACTOR INDUCTION BY PROTEASE-ACTIVATED RECEPTOR-1 REQUIRES INTACT CAVEOLIN-ENRICHED MEMBRANE MICRODOMAINS IN HUMAN ENDOTHELIAL CELLS
Pignoloni P.	-	PHARMACOKINETICS OF THE REFORMULATED B-DOMAIN DELETED RECOMBINANT FACTOR VIII (BDD-RFVIII) CONCENTRATE USING CHROMOGENIC AND ONE-STAGE ASSAYS WITH POOLED NORMAL PLASMA (PNP) AND REFACTO LABORATORY STANDARD (RLS)
Pijoan J.	-	CANCER AND VENOUS THROMBOEMBOLISM: ROLE OF GENETIC POLYMORPHISMS IN SELECTINS AND TISSUE FACTOR
	-	THE GENOTYPE BC OF THE VNTR POLIMORPHISM OF THE PLATELET GLYCOPROTEIN IB-ALPHA IS RELATED TO ASPIRIN TREATMENT FAILURE IN PATIENTS WITH ISCHEMIC STROKE
	-	VENOUS THROMBOEMBOLISM IN YOUNG PATIENTS: ROLE OF GENETIC POLYMORPHISMS IN SELECTINS AND TISSUE FACTOR
Pikver R.	-	PLATELET AGGREGATION INHIBITING COMPONENTS FROM VIPERA LEBETINA SNAKE VENOM
Piletz J.E.	-	EFFECT OF ANTIDEPRESSANT DRUG TREATMENT ON INFLAMMATORY AND PLATELET ACTIVATION BIOMARKERS IN DEPRESSION
Pilgrim S.	-	PRELIMINARY PERFORMANCE DATA OF A NEW QUANTITATIVE AND SENSITIVE D-DIMER ASSAY
Pili C.	-	THE COURSE OF D-DIMER AND FACTOR VIII LEVELS DURING THE ACUTE PHASE OF LEG DEEP VENOUS THROMBOSIS AND RELATIONSHIP WITH THE THROMBOTIC BURDEN
	-	G20210A PROTHROMBIN MUTATION IS MORE FREQUENT IN PATIENTS WITH ADVANCED STAGES OF PERIPHERAL ARTERIAL DISEASE (PAD)
Pillitteri D.	-	EFFECT OF RFVIIA (NOVOSEVEN,) AND FEIBA (FACTOR EIGHT INHIBITOR BYPASSING ACTIVITY) ON ANTICOAGULANT-INDUCED INHIBITION OF THROMBIN GENERATION IN PLATELET-RICH PLASMA (PRP)
	-	THROMBIN-INDUCED INTERLEUKIN 1BETA SYNTHESIS IN PLATELET SUSPENSIONS: IMPACT OF CONTAMINATING LEUKOCYTES
Pina-Cabral L.	-	ROLE OF PLATELET GLYCOPROTEIN IB-ALPHA POLYMORPHISM IN PLATELET REACTIVITY
Pindur G.	-	HEMOPHILIA A INHIBITOR AND AUTOIMMUNNEUTROPENIA: CASE REPORT
Pineda J.	-	ANNEXIN A5 1 C/T POLYMORPHISM DISPLAYS A BETTER OUTCOME IN A LONG TERM FOLLOW-UP AFTER PREMATURE MYOCARDIAL INFARCTION
Pinelis V.G.	-	ANTI-APOPTOTIC EFFECTS OF SERINE PROTEINASES OF HEMOSTASIS AT GLUTAMATE-INDUCED NEUROTOXICITY
Pineo G.F.	-	ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTE ISCHEMIC STROKE PATIENTS
Ping T.	-	ORALLY ADMINISTERED HEPARIN HAS CUMULATIVE ANTITHROMBOTIC EFFECTS WHEN ADMINISTERED IN REPEATED DOSES
Pinho N.	-	SEVERE GASTROINTESTINAL BLEEDING CAUSED BY ANGIODYSPLASIA IN A PATIENT WITH GLANZMANN THROMBASTHENIA
Pini Prato G.P.	-	IN PERIODONTAL DISEASE THE INFLAMMATORY STATE IS ASSOCIATED WITH SUB-CLINICAL ATHEROSCLEROSIS
Pino M.	-	ATS-13 ACTIVITY AS A COMMON MARKER OF THE ENDOTHELIAL DYSFUNCTION DEVELOPING IN THROMBOTIC MICROANGIOPATHIES OF DIFFERENT ORIGIN
Piñon M.	-	EARLY TISSUE FACTOR-INDUCED THROMBIN GENERATION IN PLATELETS: INFLUENCE OF ASPIRIN AND ASPIRIN PLUS CLOPIDOGREL
Pinotti M.	-	COAGULATION FACTOR VII LEVELS ARE MODULATED BY THE BIOLOGICAL CLOCK
	-	RELEASE OF TISSUE FACTOR-BEARING MICROPARTICLES BY HUMAN DENDRITIC CELLS INDUCED BY STIMULATION OF MEMBRANE P2X7 RECEPTORS
	-	COAGULATION FACTOR XI LEVELS AND THE LDL RECEPTOR-RELATED PROTEIN (LRP) GENOTYPE
	-	CHARACTERIZATION OF PAR-MEDIATED SIGNALING CAPACITY OF COAGULATION FACTOR X MUTANTS
	-	INTRACELLULAR EVALUATION OF ER TARGETING ELUCIDATES A MILD FORM OF INHERITED COAGULATION DEFICIENCY
	-	U1SNRNP-MEDIATED RESCUE OF MRNA PROCESSING IMPAIRED BY SPLICING MUTATIONS IN SEVERE FACTOR VII DEFICIENCY
Pinto D.J.	-	POTENT ANTITHROMBOTIC ACTIVITY OF APIXABAN, A DIRECT FACTOR XA INHIBITOR, WITH MINIMUM BLEEDING TIME EFFECT IN RABBIT MODELS OF ARTERIAL THROMBOSIS AND HEMOSTASIS
Pinto R.V.	-	SIMULTANEOUS BLEEDING AND THROMBOSIS AS THE INITIAL PRESENTATION OF SUPERWARFARIN POISONING
Pinton P.	-	INTRACELLULAR EVALUATION OF ER TARGETING ELUCIDATES A MILD FORM OF INHERITED COAGULATION DEFICIENCY
Pinzon E.	-	BISBUDIAME, AN ESTROGEN DERIVATIVE WITH AN ANTITHROMBOTIC EFFECT
Pio S.F.	-	ABNORMAL PATTERN FOR FVIII GENE INTRON 1 INVERSION IN ONE BRAZILIAN FAMILY
Piot M.	-	TFPI LEVELS AND HAEMORRHAGIC EVENTS IN HAEMOPHILIC PATIENTS
	-	IN VITRO EFFECTS OF LEPIRUDINE, DANAPAROID AND FONDAPARINUX ON THROMBIN GENERATION IN HIT PLASMAS
Piovella F.	-	LONG TERM RESULTS OF PULMONARY ENDARTERECTOMY (PEA) IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH). THE PAVIA ENDARTERECTOMY PROGRAM
	-	LONG TERM OUTCOMES OF DEEP-VEIN THROMBOSIS IN ASIA AFTER MAJOR ORTHOPEDIC SURGERY: THE AIDA EXTENSION STUDY
	-	EFFICACY OF FONDAPARINUX IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH OR WITHOUT THROMBOEMBOLIC COMPLICATIONS
Piovella C.	-	EFFICACY OF FONDAPARINUX IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH OR WITHOUT THROMBOEMBOLIC COMPLICATIONS
Pipe S.W.	-	ANTI-OXIDANTS IMPROVE FACTOR VIII FOLDING AND SECRETION AND REDUCE CELL TOXICITY AND INFLAMMATION IN VIVO IN MICE
	-	EFFICIENT SECRETION OF BIOENGINEERED COAGULATION FACTOR VIII INTO THE MILK OF TRANSGENIC ANIMALS
	-	ANTI-OXIDANTS IMPROVE FACTOR VIII FOLDING AND SECRETION AND REDUCE CELL TOXICITY AND INFLAMMATION IN VIVO IN MICE
Pipe S.	-	THROMBOSIS AND HEMOSTASIS CENTERS PILOT SITES REGISTRY: THROMBOPHILIA SCREENING IN CHILDREN
Pipy B.	-	MICROPARTICLES FROM APOPTOTIC MONOCYTES (M-MPS) INDUCE TRANSIENT PLATELET RECRUITMENT AND TISSUE FACTOR (TF) EXPRESSION BY CULTURED HUMAN VASCULAR ENDOTHELIAL CELLS VIA A REDOX-SENSITIVE MECHANISM
Piquenot J.	-	MONOCYTE PARAMETERS TO DISCRIMINATE ESSENTIAL FROM REACTIVE THROMBOCYTOSIS
Pira A.	-	INCIDENCE OF DEEP VEIN THROMBOSIS (DVT) IN NON-SURGICAL PATIENTS AT HOSPITAL ADMISSION
Pirak A.	-	EVALUATION OF THE RELATIONSHIP BETWEEN GESTATIONAL DIABETES MELLITUS AND A HISTORY OF POLYCYSTIC OVARIAN SYNDROME
Piran S.	-	IMPAIRED ANGIOGENESIS AND ENHANCED INTRACRANIAL VASCULAR APOPTOSIS IN A MURINE MODEL OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAITP)
Pirotte B.	-	THROMBIN ACTIVITY PROFILE: A POWERFUL EX VIVO SCREENING TEST FOR THE DEVELOPMENT OF ANTICOAGULANT DRUGS
Pishva N.	-	DETERMINATION OF PROTEIN C LEVEL IN NEONATES WITH SEPSIS LIKE ILLNESS
Piskin O.	-	THE EFFECT OF EXERCISE ON FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEALTHY VOLUNTEERS
Piskunova N.	-	ENOXAPARIN VERSUS HEPARIN PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM AFTER ABDOMINAL ONCOLOGIC SURGERY: A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL
Pistelli R.	-	ISOLATED DISTAL DEEP VEIN THROMBOSIS (ID-DVT) IN THE MASTER MULTICENTER ITALIAN REGISTRY
	-	INDIVIDUAL AND CLINICAL PREDICTORS OF THE TIMING OF DIAGNOSIS OF VENOUS THROMBOEMBOLISM: RESULTS FROM THE MASTER REGISTRY
	-	PREVALENCE OF UNPROVOKED VENOUS THROMBOEMBOLISM AND OF TRANSIENT AND PERMANENT RISK FACTORS IN DIFFERENT AGE GROUPS: RESULTS OF THE MASTER REGISTRY
	-	CLINICAL CHARACTERISTICS OF CANCER ASSOCIATED ACUTE VENOUS THROMBOEMBOLISM: FINDINGS FROM THE MASTER REGISTRY
	-	DELAY IN STARTING ORAL ANTICOAGULATION IN PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM (VTE): ANALYSIS FROM THE MASTER REGISTRY
Piunno M.	-	A PROPOSAL OF SCORING SYSTEM IN ASSESSMENT OF THROMBOTIC RISK IN CANCER PATIENT. A MONOCENTRIC STUDY
Pivetta F.	-	HYPERHOMOCYSTEINEMIA AND THROMBOSIS: THE DIAGNOSTIC ROLE OF POST METHIONINE-LOAD TEST
Pivkin I.V.	-	EFFECT OF PRESENCE OR ABSENCE OF RED CELLS ON EARLY GROWTH RATES OF PLATELET MURAL THROMBI
Pixley R.	-	DOMAIN 5 PEPTIDES OF HIGH MOLECULAR MASS KININOGEN UNDERGO CONFORMATIONAL CHANGES INDUCED BY ZINC
Pizzirani C.	-	RELEASE OF TISSUE FACTOR-BEARING MICROPARTICLES BY HUMAN DENDRITIC CELLS INDUCED BY STIMULATION OF MEMBRANE P2X7 RECEPTORS
Pizzolo F.	-	INCREASED ARACHIDONIC/LINOLEIC RATIO AND A POLYGENIC MODEL OF DESATURASE POLYMORPHIMS ARE ASSOCIATED WITH INCREASED RISK OF CORONARY ARTERY DISEASE
Plahuta T.G.	-	LEVEL OF PLASMA GLYCOCALICIN IN CHILDREN WITH THROMBOCYTOPENIA
Plaimauer B.	-	IGA CLASS OF AUTOANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
	-	IGG SUBCLASS DISTRIBUTION OF ANTIBODIES AGAINST ADAMTS13 IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
	-	MILD CONGENITAL ADAMTS13 DEFICIENCY DUE TO ONE MISSENSE MUTATION TOGETHER WITH FOUR AMINO ACID POLYMORPHISMS IN A PATIENT WITH FAMILIAL RECURRENT ISCHEMIC STROKE
	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF A RVWF DRUG CANDIDATE PRODUCED UNDER SERUM-FREE CONDITIONS
Plamenova I.	-	STICKY PLATELET SYNDROME (SPS) AND PLATELET GLYCOPROTEIN POLYMORPHISMS
Planes A.	-	LONG TERM OUTCOMES OF DEEP-VEIN THROMBOSIS IN ASIA AFTER MAJOR ORTHOPEDIC SURGERY: THE AIDA EXTENSION STUDY
Planque S.A.	-	A COVALENT REACTIVE ANTIGEN ANALOG TO FACTOR VIII REDUCES ANTIBODY PRODUCTION IN MEMORY B CELLS AFTER RE-STIMULATION WITH FVIII
Plantavid M.	-	DEFICIENCY OF SRC HOMOLOGY 2 DOMAIN-CONTAINING INOSITOL 5-PHOSPHATASE 1 (SHIP1) AFFECTS PLATELET RESPONSES AND THROMBUS GROWTH
Plantier J.	-	NEUTRALIZING ANTI-FVIII ANTIBODIES HAVE A DIFFERENT IMPACT IN INHIBITING THROMBIN GENERATION
	-	WALL CLOT GROWTH IN PLASMA: EFFECT OF HIGH DOSES RECOMBINANT FVIIA
Plat A.W.	-	THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) THR325ILE AND FACTOR XII C46T POLYMORPHISMS IN ATHEROSCLEROTIC RENAL ARTERY STENOSIS
Platè M.	-	A NOVEL MECHANISM FOR CONGENITAL AFIBRINOGENEMIA BASED ON PSEUDOEXON ACTIVATION IN THE FIBRINOGEN GAMMA-CHAIN GENE
	-	MISSENSE MUTATIONS IN THE COILED-COIL REGION OF FIBRINOGEN AALPHA CHAIN CAUSE FIBRINOGEN DEFICIENCY BY IMPAIRING DIMERIZATION OF TRIMERIC INTERMEDIATES
Platokouki H.	-	MORE THAN ONE EPISODES IN CHILDHOOD ITP WITH A MEDIASTINUM OF MONTHS OR YEARS. A 30 YEARS RETROSPECTIVE ANALYSIS
Platonov A.	-	STUDY OF RECOMBINANT FACTOR VIIA ACTION MECHANISM: A MATHEMATICAL MODEL
	-	MECHANISM OF BLOOD COAGULATION TRIGGERING: A MATHEMATICAL MODEL
Platonova T.M.	-	THE NOVEL PROTEIN-PROTEIN INTERACTION IN MAMMALIAN HAEMOSTASIS SYSTEM INDUCING BY STREPTOKINASE
Platt R.	-	INHERITED THROMBOPHILIA AND PREECLAMPSIA WITHIN A COHORT OF 5337 WOMEN: RESULTS OF THE MONTREAL PREECLAMPSIA STUDY
Platteel M.	-	PROS1 ANALYSIS IN 87 PEDIGREES WITH HEREDITARY PROTEIN S DEFICIENCY DEMONSTRATES STRIKING GENOTYPE-PHENOTYPE ASSOCIATIONS
	-	VALIDATION OF THE PROTEIN C/S RATIO TO IDENTIFY CARRIERS OF A PROTEIN S GENE MUTATION
Plebani M.	-	RELATION BETWEEN ENDOTHELIAL AND PLATELETS MICROPARTICLES AND VENOUS THROMBOEMBOLISM: A CASE-CONTROL STUDY
	-	TIME COURSE OF COAGULATION FACTORS IN OVERT DISSEMINATED INTRAVASCULAR COAGULATION: A CASE STUDY
Pleines I.	-	DOUBLE-DEFICIENCY OF RAC1 AND CDC42 SEVERELY AFFECTS PLATELET PRODUCTION AND FUNCTION
	-	HOT TOPIC DEFECTIVE ACTIVATION OF PLATELET INTEGRINS IN TALIN-DEFICIENT MICE
	-	RHOA IS ESSENTIAL FOR MEGAKARYOCYTE SURVIVAL IN VIVO
	-	RAC1 IS AN EFFECTOR OF THE GPVI SIGNALING CASCADE IN PLATELETS
Plesch W.J.	-	PERFORMANCE OF THE COAGUCHEK XS PLUS SYSTEM USING LIQUID QUALITY CONTROL SAMPLES
	-	INR RESULTS OF THE COAGUCHEK XS PLUS SYSTEM ARE EQUIVALENT TO THOSE OF THE COAGUCHEK XS SYSTEM
	-	EVALUATION OF THE COAGUCHEK XS PLUS SYSTEM IN A SWISS COMMUNITY SETTING
Plescia E.	-	FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY
	-	ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
	-	ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION
	-	ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS
Plewa M.C.	-	MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
Plicner D.	-	FOLIC ACID ADMINISTRATION AND PLATELET ACTIVATION AT THE SITE OF MICROVASCULAR INJURY IN SUBJECTS WITH ELEVATED TOTAL HOMOCYSTEINE
	-	C-REACTIVE PROTEIN, LIPOPROTEIN(A) AND HOMOCYSTEINE AS CONTRIBUTORS TO FIBRIN CLOT PERMEABILITY AND LYSABILITY IN SUBJECTS SCHEDULED FOR CORONARY ARTERY BYPASS GRAFTING
Plu-Bureau G.	-	ORAL OR VAGINAL ADMINISTRATION OF ETHINYL ESTRADIOL HAS A SIMILAR IMPACT ON LIVER PROTEINS AND COAGULATION MARKERS: RESULTS OF A RANDOMIZED, CROSS-OVER STUDY
	-	IMPACT OF RISK FACTORS ASSOCIATED WITH VENOUS THROMBOSIS IN CYPROTERONE ACETATE AND ETHYNIL-ESTRADIOL USERS OR OTHER ORAL CONTRACEPTIVES USERS AND POSSIBLY PREVENTABLE CASES
Plug I.I.	-	OVERWEIGHT IN DUTCH HAEMOPHILIA PATIENTS
Plug I.	-	SELF-RATED HEALTH PREDICTS MORTALITY IN PATIENTS WITH HEMOPHILIA
Plug T.	-	UNRAVELING THE MECHANISM OF INACTIVATION OF ACTIVATED TAFI
Plughnikova T.A.	-	PREVALENCE OF THROMBOPHILIA IN WOMEN WITH PREGNANCY LOSS AND GESTATIONAL OUTCOME IN WOMEN WITH DIAGNOSED THROMBOPHILIA FOLLOWING ANTITHROMBOTIC THERAPY
Plushch M.	-	USE OF RECOMBINANT FACTOR VIIA IN CARDIOSURGERY PATIENTS, INCLUDING NEONATES AND INFANTS UNDER 1 YEAR OF AGE
Plutecka H.	-	THE ADDITIVE ANTIPLATELET ACTION OF CLOPIDOGREL IN PATIENTS WITH CORONARY ARTERY DISEASE TREATED WITH ASPIRIN
Pluthero F.G.	-	PLATELET FUNCTION THROMBOELASTOGRAPHY (PFT)
Pluyshch O.P.	-	EFFICACY AND SAFETY OF FVIII WITH PEGYLATED LIPOSOMES IN HAEMOPHILIA A
Plyusch O.	-	USE OF A HIGH PURITY FACTOR IX (FIX) CONCENTRATE IN SURGERY
Plyushch O.P.	-	HOME TREATMENT WITH RECOMBINANT VIIA FACTOR IN HEMOPHILIA PATIENTS WITH INHIBITOR
	-	FIRST EXPERIENCE WITH IMMUNE TOLERANCE INDUCTION IN HAEMOPHILIA A PATIENTS WITH INHIBITOR TO FACTOR VIII IN RUSSIA
Plyushch O.	-	TRANSITION TO STANDARD HAEMOSTATIC THERAPY SCHEMES OF HEMOPHILIA IN RUSSIA (THE NATIONAL TREATMENT PROTOCOL FOR HEMOPHILIA PATIENTS)
Pochet L.	-	THROMBIN ACTIVITY PROFILE: A POWERFUL EX VIVO SCREENING TEST FOR THE DEVELOPMENT OF ANTICOAGULANT DRUGS
Pociot F.	-	STRATEGIES FOR CHARACTERIZING THE PHOSPHO- AND GLYCOPROTEOMES OF MICROPARTICLES DERIVED FROM INTERLEUKIN-1BETA STIMULATED PANCREATIC BETA-CELLS
Pock K.	-	PRODUCT FEATURES OF THE NOVEL GENERATION VWF/FVIII CONCENTRATE IN A COMPARISON WITH FIRST GENERATION PRODUCTS
	-	VWF:RCO ASSAYS USING AUTOMATED SYSTEMS FOR VWF/FVIII CONCENTRATES REQUIRE ADJUSTMENT OF ASSAY REAGENTS, COMPOSITION AND PERFORMANCE PARAMETERS
	-	THROMBIN GENERATION CAPACITY IS IMPAIRED IN METHYLENE-BLUE (MB) TREATED PLASMA UNITS COMPARED TO SINGLE-DONOR FFP, A PHARMACEUTICALLY LICENSED COAGULATION ACTIVE AND SOLVENT-DETERGENT (S/D) TREATED PLASMA PRODUCT AND A UNIVERSALLY APPLICABLE S/D-PLASMA UN
Pocsai Z.	-	MODULATION OF THE RISK OF CORONARY ARTERY DISEASE BY THE INTERACTION BETWEEN FACTOR XIII SUBUNIT A VAL34LEU POLYMORPHISM AND FIBRINOGEN CONCENTRATION IN THE HUNGARIAN POPULATION
Podbregar M.	-	T1-WEIGHTED MAGNETIC RESONANCE IMAGING DIFFERENTIATES PLATELETS IN PULMONARY EMBOLI EX VIVO
Podda G.M.	-	MODULATION OF VON WILLEBRAND A1 DOMAIN FUNCTION BY THE HOMOLOGOUS DOMAINS A2 AND A3
	-	ROLE OF DISTINCT AMINO ACID RESIDUES IN THE INTERACTION OF SOLUBLE OR SURFACE-BOUND VON WILLEBRAND FACTOR A1 DOMAIN WITH PLATELETS
Podestá G.	-	FACTOR V IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CIRRHOSIS: USEFUL TOOL IN PATIENTS WAITING FOR LIVER TRANSPLANTATION
Podolak-Dawidziak M.	-	PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) 4G/4G GENOTYPE MAY INCREASE THE RISK OF THROMBOSIS IN SUBSET OF PATIENTS WITH PROTHROMBIN G20210A GENE MUTATION
Podorolskaya L.V.	-	EXPERIMENTAL MODEL OF THROMBOSIS IN RABBIT'S MARGINAL EAR VEIN
	-	PLASMINOGEN ACTIVATORS IN EXPERIMENTAL IMMUNE NEPHRITIS
	-	SUPERFICIAL THROMBOSIS (RATS AND RABBITS) AND ITS TREATMENT WITH THROMBOLYTIC PREPARATION LONGOLYTIN
Poetzsch B.	-	FVIII CONCENTRATES OF RECOMBINANT ORIGIN SHOW A HIGHER THROMBIN SENSITIVITY THAN PLASMA-DERIVED FVIII CONCENTRATES BUT NEARLY IDENTICAL APC-MEDIATED INACTIVATION KINETICS
	-	FACTOR VIII CONCENTRATES OF RECOMBINANT ORIGIN SHOW A HIGHER SUSCEPTIBILITY TO THROMBIN PROTEOLYSIS THAN PLASMA-DERIVED CONCENTRATES BUT NEARLY IDENTICAL INACTIVATION RATES BY ACTIVATED PROTEIN C
Pogliani E.	-	PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
Pöhlmann S.	-	THE PLATELET ACTIVATION C-TYPE LECTIN RECEPTOR CLEC-2 SIGNALS VIA A NOVEL YXXL DEPENDENT SIGNALLING CASCADE DISTINCT FROM THAT OF ITAM RECEPTORS
Pohlmann U.	-	CATHETER-RELATED THROMBOSES IN NEWBORNS
Poitevin S.	-	MONOCYTE IL-10 PRODUCED IN RESPONSE TO LPS MODULATES THROMBIN GENERATION BY INHIBITING TISSUE FACTOR EXPRESSION AND RELEASE OF ACTIVE TISSUE FACTOR-BOUND MICROPARTICLES
Polack B.	-	ANKLE REPLACEMENT IN SEVERE BLEEDING DISORDERS: RETROSPECTIVE STUDY ON 17 CASES
	-	TAFI ACTIVITY LEVELS AND RECURRENT VENOUS THROMBOEMBOLIC DISEASE
Polanski S.	-	ANTITHROMBOTIC AND ANTI-PLATELET EFFECTS LIPID-LOWERING DRUGS, HOMOCYSTEINE AND N-METHYLNICOTYNAMIDE PLASMA LEVELS IN PATIENTS WITH HYPERCHOLESTEROLEMIA
Poldermans D.	-	ADAMTS13 LEVELS ARE ASSOCIATED WITH THE RISK OF ARTERIAL THROMBOSIS IN YOUNG SUBJECTS
Poles O.	-	HYPERHOMOCYSTEINEMIA AND THROMBOSIS: THE DIAGNOSTIC ROLE OF POST METHIONINE-LOAD TEST
Polgar J.	-	OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE
Poli S.	-	POST-TREATMENT PLATELET FUNCTION PREDICTS MYOCARDIAL INJURY IN ACUTE MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PCI
Poli D.	-	THE QUALITY OF ANTICOAGULATION ON FUNCTIONAL OUTCOME AND MORTALITY FOR TIA/STROKE IN ATRIAL FIBRILLATION PATIENTS
Poli B.	-	LIPID, INFLAMMATORY AND HAEMORHEOLOGICAL PROFILES ARE SIGNIFICANTLY AFFECTED BY FARMED FISH EATING: AN INTERVENTION STUDY
Poli D.	-	QUALITY OF OAT AND VTE RECURRENCE
	-	ROLE OF D-DIMER IN COMBINATION WITH F1+2, RVO AND THROMBOPHILIA IN THE RISK OF RECURRENCE OF PATIENTS WITH A FIRST VTE EPISODE AFTER OAT WITHDRAWA
Poli S.	-	ROLE OF D-DIMER IN COMBINATION WITH F1+2, RVO AND THROMBOPHILIA IN THE RISK OF RECURRENCE OF PATIENTS WITH A FIRST VTE EPISODE AFTER OAT WITHDRAWA
	-	CLINICAL DETERMINANTS OF PLATELET FUNCTION IN PATIENTS WITH CAD UNDERGOING CORONARY ANGIOGRAPHY AND TREATED BY DUAL ANTIPLATELET THERAPY
Poli D.	-	THROMBOPHILIA IS FREQUENT IN SUPERFICIAL VEIN THROMBOSIS AND IS ASSOCIATED WITH RECURRENCE
Poli S.	-	PLATELET FUNCTION EVALUATION BY USING A NEW POINT-OF-CARE SYSTEM AND PLATELET LIGHT-TRANSMISSION AGGREGATION IN A LARGE COHORT OF CORONARY ARTERY DISEASE PATIENTS
Poli D.	-	RISK OF BLEEDING IN VERY OLD ATRIAL FIBRILLATION PATIENTS ON WARFARIN: RELATIONSHIP WITH AGEING AND CHADS2 SCORE
Polidano E.	-	CALCIUM PUMPS AND ER STRESS MODULATIONS DURING THROMBOPOIESIS
Polla M.	-	SUBSTRATE SPECIFICITY STUDY OF CARBOXYPEPTIDASE U (TAFIA): DEVELOPMENT OF HIGHLY SELECTIVE CPU SUBSTRATES AS USEFUL TOOLS FOR ASSAY DEVELOPMENT
Pollard D.	-	A MULTIDISCIPLINARY CLINIC FOR WOMEN WITH INHERITED BLEEDING DISORDERS
Poller L.	-	EXTERNAL QUALITY CONTROL FOR THE COAGUCHEK INR MEASUREMENT IMPORTANT TO CONTROL TEST STRIP QUALITY: EVIDENCE FOR LIMITED PROPORTIONAL DIFFERENCES
	-	A NATIONAL FIELD STUDY OF QUALITY ASSESSMENT (QA) OF COAGUCHEK MONITORS
	-	QUALITY ASSESSMENT OF COAGUCHEK MONITORS: COMPARATIVE ANALYSIS OF THE ECAA AND CONVENTIONAL EXTERNAL QA
Poller W.	-	VIRAL MYOCARDITIS IS A HYPERCOAGULATIVE STATE. INCREASED TISSUE FACTOR EXPRESSION AND PLASMA THROMBOGENICITY
Poller L.	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE CLINICAL STUDY
	-	LOCAL ISI CALIBRATION AND "DIRECT INR" IN CORRECTION OF REPORTED INTERNATIONAL NORMALISED RATIOS: AN INTERNATIONAL STUDY
	-	COST-EFFECTIVENESS OF COMPUTER-ASSISTED ANTICOAGULANT DOSAGE
Pollmann H.	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
	-	FINAL RESULTS OF A FEASIBILITY STUDY ON AN ELECTRONIC MONITORING SYSTEM IN HEMOPHILIA CARE
	-	SEVEN YEARS PHARMACOVIGILANCE EVALUATION WITH REFACTO: INHIBITOR DEVELOPMENT IN PREVIOUSLY TREATED AND UNTREATED HEMOPHILIA A PATIENTS
	-	ON DEMAND TREATMENT AND CONTINUOUS PROPHYLAXIS OF ADULT HAEMOPHILIA A PATIENTS: A COMPARATIVE RETROSPECTIVE DATA ASCERTAINMENT
Pollola J.	-	TREATMENT WITH RECOMBINANT ACTIVATED FVII DECREASES FVIII INHIBITOR TITLE
Polonski L.	-	P2Y12 ANTAGONIST COMPLEMENTARY TO ASPIRIN THERAPY IS SUPERIOR TO ASPIRIN ALONE IN PATIENTS AFTER CARDIOSURGERY OPERATIONS
Polyanskaya T.Y.	-	AIRWAY OBSTRUCTION CAUSED BY HEMORRHAGE IN PATIENTS (PTS) WITH INHIBITOR HEMOPHILIA
Pomerleau J.	-	EVALUATION OF THE ANTICOAGULANTS EDTA CONTAINING DISODIUM DIAZOLIDYL UREA TO PREVENT UNSOLICITED PLATELET ACTIVATION
Pommer H.	-	INFLUENCE OF THROMBOPHILIA ON VASCULAR ACCESS SURVIVAL IN CHRONIC HEMODIALYSIS PATIENTS
Pomp E.R.	-	MODERATE ALCOHOL CONSUMPTION DECREASES THE RISK OF VENOUS THROMBOSIS
	-	MAJOR CHANGES IN THE DIAGNOSTIC WORK-UP OF PULMONARY EMBOLISM BETWEEN 1999 AND 2004
	-	SMOKING INCREASES THE RISK OF VENOUS THROMBOSIS
	-	TRENDS IN THE DIAGNOSTIC WORK-UP OF DEEP VENOUS THROMBOSIS OF THE LEG BETWEEN 1999 AND 2004
Ponce O.	-	ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION
Poncelet P.	-	STANDARDIZATION OF MICROPARTICLE COUNTING USING FLOW CYTOMETRY: NEW OPTIONS AND TOOLS FOR THE CONTROL OF CRITICAL INSTRUMENT SETTINGS
Poncz M.	-	ENDOGENOUS PLATELET FACTOR 4 INCREASES ACTIVATED PROTEIN C GENERATION AND IMPROVES SURVIVAL AFTER LIPOPOLYSACCHARIDE CHALLENGE
	-	THE ROLE OF HIT PLATELET FACTOR 4 ANTIGENIC COMPLEXES ON MONOCYTE SURFACES IN THE PATHOGENESIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
	-	PLATELET FACTOR 4 EXERTS A NEGATIVE PARACRINE EFFECT ON MEGAKARYOPOIESIS THROUGH LIPOPROTEIN RELATED PROTEIN RECEPTOR-1 ON MEGAKARYOCYTIC PRECURSORS
Pongtanakul B.	-	ACCURATE BEDSIDE DIAGNOSTIC KIT FOR DETERMINING HEMOPHILIA A AND
Pönitz V.	-	ACTIVATED FACTOR XII TYPE A INDEPENDENTLY PREDICTS 12 MONTH MORTALITY IN CHEST PAIN PATIENTS
Pons D.	-	THE FACTOR VII ACTIVATING PROTEASE (FSAP) POLYMORPHISM (G534E) IS ASSOCIATED WITH A DECREASED RISK FOR RESTENOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION
Pontara E.	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
	-	A TYPE VICENZA-LIKE VON WILLEBRAND DISEASE NOT ASSOCIATED WITH VWF GENE MUTATION NOR ANTI-VWF ANTIBODIES
	-	A NEW (I1372S) MUTATION IN THE A1 DOMAIN OF VON WILLEBRAND FACTOR ASSOCIATED WITH A TYPE 2B-LIKE VON WILLEBRAND DISEASE PHENOTYPE
	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
Pontigon A.	-	HEMORRHAGIC TRANSFORMATION OF ARTERIAL ISCHEMIC STROKE IN CHILDREN
	-	OCCIPITAL BONE COMPRESSION OF THE SUPERIOR SAGITTAL SINUS AS A CONTRIBUTORY FACTOR IN NEONATAL CEREBRAL SINOVENOUS THROMBOSIS
	-	THE SAFETY OF ANTICOAGULANTS IN PEDIATRIC ARTERIAL ISCHEMIC STROKE: PRELIMINARY RESULTS
Pooga M.	-	IMMUNE RESPONSE TO ADMINISTRATION OF PLASMA-DERIVED COAGULATION FACTOR VIII IN FACTOR VIII-DEFICIENT MICE
Poole A.W.	-	PROTEOMIC ANALYSIS OF THE SHP-1 INTERACTOME IN HUMAN PLATELETS
	-	REDUNDANT AND NON-REDUNDANT ROLES FOR CLASSICAL PKC ISOFORMS IN THE REGULATION OF PLATELET FUNCTION
Poon M.	-	ECONOMIC EVALUATION OF POINT-OF-CARE MONITORING DEVICES FOR LONG-TERM ORAL ANTICOAGULATION THERAPY
	-	CHALLENGES IN DEFINING TYPE 2M VON WILLEBRAND DISEASE: RESULTS FROM A CANADIAN COHORT STUDY
	-	DO POINT OF CARE DEVICES IMPROVE OUTCOMES IN PATIENTS ON ORAL ANTICOAGULANT THERAPY
Poonoose P.	-	POLYMORPHISMS IN COAGULANT AND INFLAMMATORY GENES MODIFY THE PHENOTYPE OF SEVERE HEMOPHILIA A AND B
Poort S.R.	-	FACTOR IX GENE VARIANTS AND THE RISK OF VENOUS THROMBOSIS
Poplavsky J.	-	THROMBIN GENERATION TEST IN THE MONITORING OF PROTHROMBIN COMPLEX CONCENTRATES
Popov E.G.	-	MODULATION OF PLATELET REACTIVITY BY ERYTHROCYTES IN CORONARY ARTERY DISEASE PATIENTS TAKING ASPIRIN
Popov J.	-	IDENTIFICATION OF VON WILLEBRAND DISEASE TYPE 2N BY VWF-FVIII BINDING ACTIVITY ASSAY IN PATIENTS AND HETEROZYGOUS CARRIERS
Popov E.G.	-	CIRCULATING PROPLATELETS IN HEALTHY SUBJECTS AND PATIENTS
Popovic M.	-	THROMBIN STIMULATION AMPLIFIES MONOCYTIC/ENDOTHELIAL CELL CROSS-TALK AND SUBSEQUENT MCP-1 RELEASE THROUGH FRACTALKINE BINDING
Popovic S.	-	INVESTIGATION OF ACQUIRED VON WILLEBRAND'S SYNDROME IN PATIENTS WITH HYPOTHYROIDISM
Poredos P.	-	ENDOTHELIAL FUNCTION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND HISTORY OF VENOUS THROMBOSIS
Porreca E.	-	LEPTIN INDUCES TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES
Porta B.	-	E-SELECTIN AND TFPI ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS IN STABLE CORONARY PATIENTS: THE BASELINE FINDINGS OF THE MIAMI STUDY
Porte P.	-	CONTRIBUTION OF CHROMATOGRAPHY STEPS IN PRION REMOVAL IN PLASMA-DERIVED PRODUCT MANUFACTURING
	-	EFFICIENT PRION REMOVAL DURING THE MANUFACTURING PROCESS OF BETAFACT, A HIGH-PURITY PLASMA DERIVED FACTOR IX
Pos W.	-	HUMAN VH1-69 GERMLINE GENE ENCODED ANTI-SPACER DOMAIN ANTIBODIES THAT DEVELOP IN PATIENTS WITH ACQUIRED TTP INTERFERE WITH THE BINDING OF ADAMTS13 TO VWF
Post J.M.	-	A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS
Pötzsch B.	-	ACTIVATED PROTEIN C INHIBITION BY PROTEIN C INHIBITOR IS NOT ACCELERATED BY THE SYNTHETIC PENTASACCHARIDE FONDAPARINUX
	-	DESIGN AND IN VITRO CHARACTERIZATION OF A PHOTODYNAMIC ANTICOAGULANT
Pouard P.	-	EFFECT OF HIGH-DOSE APROTININ ON PLATELET FUNCTION AFTER NORMOTHERMIC CARDIOPULMONARY BYPASS IN CHILDREN CARDIAC SURGERY
Poujol-Robert A.	-	A SCREENING TEST FOR THROMBOSIS RISK FACTORS AS A MARKER OF LIVER FIBROSIS IN CHRONIC HEPATITIS C
Poulin R.	-	ELTROMBOPAG, AN ORAL, NON-PEPTIDE PLATELET GROWTH FACTOR, INCREASES PLATELET COUNTS AND DECREASES BLEEDING IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA IN A PHASE III STUDY
Poulsen T.S.	-	RESPONSE TO ASPIRIN AND CLOPIDOGREL IN HEALTHY MEN
	-	TEST OF ASPIRIN RESISTANCE
Pouplard C.	-	INFLUENCE OF THE SOURCE OF PHOSPHOLIPIDS FOR APTT-BASED FIX ASSAYS AND POTENTIAL CONSEQUENCES FOR THE DIAGNOSIS OF MILD/MODERATE HAEMOPHILIA B
	-	PERFORMANCES OF A NEW ELISA (ZYMUTEST HIA) FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
	-	IS THE RISK OF VENOUS THROMBOEMBOLISM HIGHER WITH CYPROTERONE CONTRACEPTIVES?
Poupon R.	-	A SCREENING TEST FOR THROMBOSIS RISK FACTORS AS A MARKER OF LIVER FIBROSIS IN CHRONIC HEPATITIS C
	-	A NEW MODE OF PROTHROMBIN TIME (PT) REPORTING SPECIFIC FOR LIVER DISEASES
Pour L.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Pourfathollah A.	-	FACTOR V MUTATIONS IN IRANIAN PATIENTS WITH ACTIVATED PROTEIN C RESISTANCE AND VENOUS THROMBOSIS
Pouzol P.	-	TAFI ACTIVITY LEVELS AND RECURRENT VENOUS THROMBOEMBOLIC DISEASE
Povazan L.	-	PROPHYLACTIC APPROACH TO WOMEN WITH THROMBOPHILIA AND REPEATED SPONTANEOUS ABORTIONS
Powazniak Y.	-	TESTOSTERONE INDUCES PHOSPHORYLATION OF P38 AND JNK IN HUVEC
	-	EFFECT OF NYTROXYL (HNO) AND NITRIC OXIDE (NO) ON PROTEIN KINASE ACTIVATION PATHWAY IN HUMAN PLATELET
	-	VWF-CLEAVING SERINE PROTEASES ISOLATION DIFFERENT FROM ADAMTS13
	-	THREE NEW POLYMORPHISMS LOCATED IN THE INTRON 2 OF THE ADAMTS13 GENE
Powell C.	-	THE BIPHASIC APTT WAVEFORM AS A BIOMARKER FOR TARGETING TREATMENT WITH RECOMBINANT ACTIVATED PROTEIN C (APC)
Powell J.S.	-	REFORMULATED RECOMBINANT FACTOR IX: EFFICACY AND SAFETY IN PREVIOUSLY TREATED PATIENTS WITH MODERATELY SEVERE TO SEVERE HEMOPHILIA B
Powell S.	-	PRECLINICAL PHARMACOLOGY OF AV513 INCLUDING ORAL EFFICACY IN SEVERE HEMOPHILIA A DOGS
Pownall H.	-	SHEAR-INDUCED DISULFIDE BOND FORMATION REGULATES ADHESION ACTIVITY OF VON WILLEBRAND FACTOR
Pozgajova M.	-	HOT TOPIC DEFECTIVE ACTIVATION OF PLATELET INTEGRINS IN TALIN-DEFICIENT MICE
	-	RAC1 IS AN EFFECTOR OF THE GPVI SIGNALING CASCADE IN PLATELETS
	-	INHIBITION OF GPIB, BUT NOT GPIIB/IIIA, IMPROVES EXPERIMENTAL STROKE OUTCOME WITHOUT BLEEDING COMPLICATIONS
Pozner R.G.	-	GALECTIN-1 BINDING TO PLATELETS: A NEW MECHANISM FOR PLATELET ACTIVATION
	-	ROLE OF PPAR-GAMMA ACTIVATION IN MEGAKARYOCYTOPOIESIS
	-	IMPAIRED THROMBOPOIESIS AFTER STEM CELL INFECTION WITH JUNIN VIRUS
	-	DIFFERENTIATION OF CD34+ CELLS MEDIATED BY THROMBOPOIETIN AND MONOCYTES/MACROPHAGES
Pozzi N.	-	THE Na+-BOUND AND Na+-FREE CONFORMATION OF THROMBIN PROBED BY SOLUTION STUDIES
Prabhakar S.	-	INVESTIGATION OF THROMBOPHILIA DURING PREGNANCY AND PUERPERIUM: A STUDY FROM NORTH INDIA
Prabhakaran K.	-	GASTROINTESTINAL BLEEDING DUE TO MECKEL'S DIVERTICULUM IN A HEMOPHILIAC WITH INHIBITORS
Prager G.W.	-	UROKINASE (UPA) INDUCES ENDOTHELIAL CELL SURVIVAL VIA THE X-LINKED INHIBITOR OF APOPTOSIS PROTEIN (XIAP)
Prakash K.J.	-	TETRASPANIN CD9 MODULATES VASCULAR SMOOTH MUSCLE CELL MIGRATION AND PROLIFERATION IN VITRO AND NEOINTIMA FORMATION IN VIVO
Prandoni P.	-	FACTOR V LEIDEN IS ASSOCIATED WITH MORE DISTAL LOCATION OF DEEP VEIN THROMBOSIS OF THE LEG
	-	GRADUATED COMPRESSION STOCKINGS (GCS) VERSUS LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) FOR PREVENTION OF DEEP VEIN THROMBOSIS (DVT) AFTER KNEE ARTHROSCOPY (KA). A RANDOMISED STUDY (KANT)
	-	OUTCOME OF PATIENTS WITH SUSPECTED SYMPTOMATIC DEEP-VEIN THROMBOSIS (DVT) AND A NORMAL ULTRASOUND-BASED INITIAL DIAGNOSTIC WORKUP. A PROSPECTIVE STUDY
	-	QUALITY OF ORAL ANTICOAGULANT TREATMENT AND RISK OF SUBSEQUENT RECURRENT THROMBOEMBOLISM IN PATIENTS WITH DEEP VENOUS THROMBOSIS. A PROSPECTIVE COHORT STUDY
	-	METABOLIC SYNDROME AND HYPERHOMOCYSTEINEMIA IN PATIENTS WITH DEEP VEIN THROMBOSIS: A CASE-CONTROL STUDY
	-	LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
	-	CLINICAL OUTCOMES DURING BEMIPARIN POST-MARKETING OBSERVATIONAL STUDIES ON PROPHYLAXIS OF VENOUS THROMBOEMBOLISM
	-	D-DIMER AS AN ADJUNCT TO COMPRESSION ULTRASONOGRAPHY IN PATIENTS WITH SUSPECTED RECURRENT IPSILATERAL DEEP VEIN THROMBOSIS. A PROSPECTIVE COHORT STUDY
	-	THROMBOPHILIA AS A PREDICTOR OF RESIDUAL VEIN THROMBOSIS. A PROSPECTIVE COHORT STUDY
	-	LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY
	-	FONDAPARINUX IN THE TREATMENT OF SYMPTOMATIC, ISOLATED SUPERFICIAL THROMBOPHLEBITIS (ST): THE CALISTO TRIAL
	-	THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM AFTER DISCONTINUING ANTICOAGULATION IN PATIENTS WITH ACUTE PROXIMAL DEEP VEIN THROMBOSIS OR PULMONARY EMBOLISM. A PROSPECTIVE COHORT STUDY
	-	THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM AMONG HETEROZYGOUS CARRIERS OF FACTOR V LEIDEN OR PROTHROMBIN G20210A MUTATION. A SYSTEMATIC REVIEW OF PROSPECTIVE STUDIES
	-	THE RISK OF FATAL PULMONARY EMBOLISM AFTER STOPPING ANTICOAGULANT THERAPY IN PATIENTS WITH VENOUS THROMBOEMBOLISM
	-	VENOUS THROMBOEMBOLISM AND SUBSEQUENT HOSPITALIZATION DUE TO ACUTE CARDIOVASCULAR EVENTS. A 20 YEARS FOLLOW-UP STUDY
	-	PREVENTION OF RECURRENT THROMBOEMBOLISM BY ADJUSTING THE DURATION OF ANTICOAGULATION ACCORDING TO RESIDUAL VEIN THROMBOSIS. A RANDOMIZED STUDY
	-	COMPARISON OF FOUR CLINICAL PREDICTION MODELS IN PATIENTS WITH SUSPECTED PULMONARY EMBOLISM
	-	THROMBOPROPHYLAXIS WITH BEMIPARIN STARTED 6 HOURS AFTER HIP OR KNEE REPLACEMENT SURGERY: REVIEW OF CLINICAL AND POSTMARKETING EXPERIENCE
	-	VENOUS THROMBOEMBOLISM AND ATHEROSCLEROSIS: IS THERE A LINK?
Prasad S.	-	PRECLINICAL PHARMACOLOGY OF AV513 INCLUDING ORAL EFFICACY IN SEVERE HEMOPHILIA A DOGS
	-	AV513 ENHANCES TISSUE FACTOR ACTIVITY AND STIMULATES THROMBIN GENERATION IN HEMOPHILIA A PLASMA
Prasad A.	-	DE NOVO ATOMIC FORCE MICROSCOPY OF INTRACORONARY THROMBUS: NEW INSIGHTS INTO FIBRIN CLOT ARCHITECTURE AND IMPLICATIONS FOR FIBRINOLYSIS
Prashun D.	-	PROTEIN S (PS) CONTAINS ZINC THAT IS ESSENTIAL FOR DIRECT ANTICOAGULANT ACTIVITY
Pratesi C.	-	GENETIC ANALYSIS OF 56 POLYMORPHISMS IN 18 GENES INVOLVED IN HOMOCYSTEINE METABOLISM IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM
Pratesi G.	-	GENETIC ANALYSIS OF 56 POLYMORPHISMS IN 18 GENES INVOLVED IN HOMOCYSTEINE METABOLISM IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM
	-	ABDOMINAL AORTIC ANEURYSM AND CAROTID ARTERY DISEASE: GENE EXPRESSION PROFILING OF TWO ATHEROSCLEROTIC DISEASES
Pratesi C.	-	ABDOMINAL AORTIC ANEURYSM AND CAROTID ARTERY DISEASE: GENE EXPRESSION PROFILING OF TWO ATHEROSCLEROTIC DISEASES
Pratesi G.	-	PROTEIN Z PLASMA LEVELS IN DIFFERENT LOCALIZATIONS OF ATHEROSCLEROTIC DISEASE
Pratesi C.	-	PROTEIN Z PLASMA LEVELS IN DIFFERENT LOCALIZATIONS OF ATHEROSCLEROTIC DISEASE
Prati C.	-	LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY
Pratima R.S.	-	CIRCULATING ANTIBODIES TO HEAT SHOCK PROTEINS AND THEIR ASSOCIATION WITH ATHEROTHROMBOTIC PHENOTYPES
Pratt K.P.	-	C2 DOMAIN T-CELL EPITOPES IN HEMOPHILIA A SUBJECTS WITH THE MUTATION A2201P
Prechel M.	-	DIFFERENTIAL EFFECTS OF FXA INHIBITORS AND HEPARINS IN SIMULATED ARTERIAL AND VENOUS THROMBOSIS
	-	POTENTIAL OF THE FACTOR XA INHIBITOR RIVAROXABAN FOR THE ANTICOAGULATION MANAGEMENT OF PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
Prechel M.M.	-	PLATELET-BOUND PF4 IS TARGETED BY HIT ANTIBODIES IN THE ABSENCE OF HEPARIN
Preda I.	-	STUDY OF IN VIVO AND IN VITRO ADMINISTERED ASPIRIN'S ANTIPLATELET EFFECT: POSSIBLE MECHANISMS OF ASPIRIN RESISTANCE
Préda I.	-	HIGH NOREPINEPHRINE LEVEL IS ASSOCIATED WITH SIGNIFICANT PLATELET HYPERREACTIVITY DEMONSTRATED BY INCREASED PLATELET P-SELECTIN POSITIVITY, ADENOSIN DIPHOSPHATE AND COLLAGEN INDUCED AGGREGATIONS IN STABLE CORONARY HEART DISEASE PATIENTS ON DUAL ANTIPLATEL
Preda I.	-	CLOPIDOGREL TREATMENT SIGNIFICANTLY DECREASES CIRCULATING ENDOTHELIAL CELL COUNT IN PATIENTS WITH STABLE ANGINA
	-	ASSESSMENT OF PLATELET P2Y1 FUNCTION IN CLOPIDOGREL-TREATED ISCHEMIC HEART DISEASE PATIENTS
Preiss J.R.	-	DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
Preissner K.T.	-	DOUBLE STRANDED RNA-MEDIATED MODULATION OF THE BALANCE BETWEEN TISSUE FACTOR AND THROMBOMODULIN ON THE ENDOTHELIUM: RELEVANCE FOR DYSFUNCTIONAL HAEMOSTASIS IN VIRAL INFECTIONS
	-	HEPARANASE MODULATES HEPARINOIDS ANTICOAGULANT ACTIVITIES VIA NON-ENZYMATIC MECHANISMS
	-	FACTOR VII ACTIVATING PROTEASE INHIBITS THE UROKINASE PLASMINOGEN ACTIVATION SYSTEM AND STIMULATES GELATINASES (MATRIX METALLOPROTEINASES-2 AND -9) IN VASCULAR SMOOTH MUSCLE AND ENDOTHELIAL CELLS
	-	FACTOR VII ACTIVATING PROTEASE (FSAP) REGULATES CELL ADHESION AND MOTILITY BY MULTIPLE MECHANISMS
	-	FACTOR VII ACTIVATING PROTEASE INHIBITS VASCULAR ENDOTHELIAL GROWTH FACTOR-MEDIATED PROGENITOR CELL HOMING AND DIFFERENTIATION INTO ENDOTHELIAL CELLS
	-	THE UROKINASE SYSTEM REGULATES THE MOBILIZATION, HOMING AND DIFFERENTIATION OF PROGENITOR CELLS INTO ENDOTHELIAL CELLS
	-	INHIBITION OF PLATELET-DERIVED GROWTH FACTOR-BB (PDGF-BB) FUNCTION BY FACTOR VII ACTIVATING PROTEASE (FSAP): ROLE OF PROTEASE NEXIN-1 (PN-1) AND LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP)
	-	FACTOR VII ACTIVATING PROTEASE (FSAP)
	-	INDUCTION OF ENDOTHELIAL CELL HYPERPERMEABILITY BY EXTRACELLULAR RNA
	-	STRUCTURE-FUNCTION ANALYSIS OF THE BINDING PROPERTIES AND ENZYMATIC ACTIVITY OF FACTOR VII ACTIVATING PROTEASE (FSAP) USING RECOMBINANT MUTANT PROTEINS
Pressley F.	-	VENOUS THROMBOSIS (VTE) HAS AN ADVERSE IMPACT ON THE SURVIVAL IN PATIENTS WITH MALIGNANCY
Pretzlaff R.	-	SUCCESSFUL ANTICOAGULATION OF INFANTS TO ADULTS WITH BIVALIRUDIN IN EXTRACORPOREAL MEMBRANOUS OXYGENATION (EMCO)
Previdi P.	-	A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS
Pribble J.	-	PHASE 3 STUDY COMPARING RECOMBINANT HUMAN THROMBIN AND BOVINE THROMBIN FOR SURGICAL HEMOSTASIS
Price V.	-	MANAGEMENT OF VENOUS AND ARTERIAL THROMBOSIS IN CHILDREN
Price E.A.	-	NASCOLA SURVEY OF HIT TESTING IN NORTH AMERICA
Priest P.	-	THROMBIN GENERATION & ROTEM TESTS IN PREGNANCY: POTENTIAL FOR MONITORING ADEQUACY OF LOW MOLECULAR WEIGHT HEPARIN ADMINISTRATION
Prieto E.	-	THALIDOMIDE AND THROMBOPROPHYLAXIS: TO WHOM AND WHEN
Prihartono J.	-	METABOLIC SYNDROME IN ISCHEMIC STROKE PATIENTS' CHILD
Primignani M.	-	THE INTERNATIONAL NORMALIZED RATIO TO PRIORITIZE PATIENTS FOR LIVER TRANSPLANTATION. PROBLEMS AND SOLUTIONS
Principessa L.	-	PERSISTENT TXA2 PRODUCTION IN PATIENTS CHRONICALLY TREATED WITH ASPIRIN: RESIDUAL COX-1 ACTIVITY OR COX-2 ACTIVATION?
Prins M.H.	-	CLINICALLY SUSPECTED ACUTE RECURRENT PULMONARY EMBOLISM: A DIAGNOSTIC CHALLENGE
	-	THROMBIN GENERATION IN PATIENTS AFTER RECENT DEEP VEIN THROMBOSIS VERSUS HEALTHY CONTROLS
	-	PREVENTION OF RECURRENT THROMBOEMBOLISM BY ADJUSTING THE DURATION OF ANTICOAGULATION ACCORDING TO RESIDUAL VEIN THROMBOSIS. A RANDOMIZED STUDY
	-	CONVENIENCE OF THE NEW LONG-ACTING ANTICOAGULANT IDRAPARINUX (IDRA) VERSUS VITAMIN K ANTAGONIST (VKA) IN PATIENTS WITH DEEP VENOUS THROMBOSIS (DVT)
	-	MULTINATIONAL DEVELOPMENT OF A QUESTIONNAIRE ASSESSING PATIENT SATISFACTION WITH ANTI-COAGULANT TREATMENT
	-	THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM AMONG HETEROZYGOUS CARRIERS OF FACTOR V LEIDEN OR PROTHROMBIN G20210A MUTATION. A SYSTEMATIC REVIEW OF PROSPECTIVE STUDIES
Prins M.	-	IL 1A 899C/T AND IL4 589C/T ARE ASSOCIATED WITH VENOUS THROMBOEMBOLISM
Prins M.H.	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH MILD HYPERHOMOCYSTEINEMIA. A RETROSPECTIVE FAMILY COHORT STUDY
	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH INCREASED LEVELS OF FVIII:C. A RETROSPECTIVE FAMILY COHORT STUDY
	-	DOES THE PRESENCE OF MULTIPLE INHERITED THROMBOPHILIC DEFECTS EXPLAIN THE INCREASED RISK OF ARTERIAL THROMBOTIC EVENTS IN PATIENTS WITH PRIOR VENOUS THROMBOEMBOLISM?
	-	LEVELS OF FACTOR VIII (FVIII), D-DIMER AND THROMBIN GENERATION (TG) IN PATIENTS AFTER ACUTE DEEP VEIN THROMBOSIS (DVT)
	-	THROMBOPHILIC RISK FACTORS FOR FIRST VENOUS THROMBOEMBOLISM, RECURRENCE AND ITS IMPLICATIONS: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY
	-	QUALITY OF ORAL ANTICOAGULANT TREATMENT AND RISK OF SUBSEQUENT RECURRENT THROMBOEMBOLISM IN PATIENTS WITH DEEP VENOUS THROMBOSIS. A PROSPECTIVE COHORT STUDY
Prins M.	-	THE VALUE OF PET- SCANNING IN THE DETECTION OF OCCULT CANCER IN PATIENTS WITH VENOUS THROMBOEMBOLISM
Prins M.H.	-	HYPERHOMOCYSTEINEMIA IS NOT A RISK FACTOR FOR VENOUS AND ARTERIAL THROMBOSIS, BUT AN EPIPHENOMENON: RESULTS FROM A LARGE RETROSPECTIVE FAMILY COHORT STUDY
	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH PROTHROMBIN 20210A. A RETROSPECTIVE FAMILY COHORT STUDY
Prisco D.	-	EFFICACY OF OMEGA-3 FATTY ACIDS IN LOWERING LIPOPROTEIN(A) LEVELS
	-	POST-TREATMENT PLATELET FUNCTION PREDICTS MYOCARDIAL INJURY IN ACUTE MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PCI
	-	MAXIMAL AND LATE ADP INDUCED PLATELET AGGREGATION IN CORONARY ARTERY DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY
	-	THE QUALITY OF ANTICOAGULATION ON FUNCTIONAL OUTCOME AND MORTALITY FOR TIA/STROKE IN ATRIAL FIBRILLATION PATIENTS
	-	HIGH-THROUGHPUT MULTIPLEX SINGLE-NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS IN GENES INVOLVED IN METHIONINE METABOLISM
	-	ROLE OF D-DIMER IN COMBINATION WITH F1+2, RVO AND THROMBOPHILIA IN THE RISK OF RECURRENCE OF PATIENTS WITH A FIRST VTE EPISODE AFTER OAT WITHDRAWA
	-	VITAMIN B6 AND FOLIC ACID ARE RISK FACTORS FOR RETINAL VEIN OCCLUSION INDEPENDENTLY OF HOMOCYSTEINE LEVELS
	-	QUALITY OF OAT AND VTE RECURRENCE
	-	LIPOPROTEIN (A) AND VENOUS THROMBOEMBOLISM IN ADULTS: A META-ANALYSIS
	-	PLATELET FUNCTION EVALUATION BY USING A NEW POINT-OF-CARE SYSTEM AND PLATELET LIGHT-TRANSMISSION AGGREGATION IN A LARGE COHORT OF CORONARY ARTERY DISEASE PATIENTS
	-	RISK OF BLEEDING IN VERY OLD ATRIAL FIBRILLATION PATIENTS ON WARFARIN: RELATIONSHIP WITH AGEING AND CHADS2 SCORE
	-	THROMBOPHILIA IS FREQUENT IN SUPERFICIAL VEIN THROMBOSIS AND IS ASSOCIATED WITH RECURRENCE
	-	HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION
	-	HOMOCYSTINURIA AND CARDIOVASCULAR MANIFESTATIONS: 5 ITALIAN CASES
	-	ASSESSMENT OF CLOT LYSIS TIME TISSUE FACTOR-INDUCED BY EXOGENOUS T-PA IN HEALTHY SUBJECTS BY USING A MICROPLATE READER
Pritchard D.	-	ACTIVATED FACTOR XII TYPE A INDEPENDENTLY PREDICTS 12 MONTH MORTALITY IN CHEST PAIN PATIENTS
Procházka M.	-	FACTOR V LEIDEN AND PLACENTAL PATHOLOGY
Procházková J.	-	FACTOR V LEIDEN AND PLACENTAL PATHOLOGY
Prochazkova J.	-	THROMBIN GENERATION TEST AN EXPERIENCE OF ONE CENTRE IN THROMBOPHILIA PATIENTS
Prochnow S.	-	NON-RESPONSE TO ASPIRIN (ASA) IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (PAOD); A PROSPECTIVE STUDY
	-	NON-RESPONSE TO CLOPIDOGREL IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (PAOD); A PROSPECTIVE STUDY
Proietti M.	-	OBSERVATIONAL STUDY OF 150 WOMEN WITH INHERITED THROMBOPHILIA AND RECURRENT PREGNANCY LOSS
Protty M.B.	-	CD148 IS AN ESSENTIAL POSITIVE REGULATOR OF ITAM AND INTEGRIN RECEPTOR SIGNALLING IN PLATELETS
Proulle V.	-	ASSESSMENT OF THE PREDICTIVE VALUE OF PFA-100 TM OCCLUSION TIME CONCERNING THE HAEMORRHAGIC RISK OF TRANSPARIETAL NEEDLE LIVER BIOPSY IN CHILDREN
	-	A NEW LEU123 TO PRO MUTATION IN THE FIFTH LEUCINE-RICH REPEAT OF GLYCOPROTEIN IBALPHA IN A BERNARD-SOULIER PATIENT INDUCES DEFECTIVE SHEAR-DEPENDENT CELL ADHESION ON VON WILLEBRAND FACTOR
Provost N.	-	ROTEM THROMBOELASTOMETRY IN OBSTETRIC: NEAR PATIENT-TEST AS AN EARLY PREDICTOR OF POST-PARTUM HEMORRHAGE (PPH)
Prüller F.	-	ENDOGENOUS THROMBIN POTENTIAL IN 3183 PARTICIPANTS OF THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY
Pruss C.	-	THE EFFECT OF EXERCISE ON INDIVIDUALS WITH TYPE 1 AND TYPE 2B VON WILLEBRAND DISEASE (VWD)
Pruss C.M.	-	POLYMORPHIC AND MUTAGENIC SEQUENCE CHANGES IN THE A1 AND A2 DOMAINS OF VON WILLEBRAND FACTOR (VWF) RESULT IN ALTERATIONS TO ADAMTS13 CLEAVAGE EFFICIENCY
Pruthi R.K.	-	VON WILLEBRAND FACTOR (VWF) MULTIMER ANALYSIS BY IN-GEL IMMUNOSTAINING AND INFRARED IMAGING
	-	A HIGHLY-SENSITIVE PLASMA VON WILLEBRAND FACTOR (VWF):RISTOCETIN COFACTOR ACTIVITY ASSAY BY FLOW CYTOMETRY
Prutsch N.	-	MONITORING HEPARIN LEVELS IN CHILDREN DURING CARDIAC CATHETERIZATION: COMPARISON OF ACTIVATED CLOTTING TIME, ACTIVATED PARTIAL PROTHROMBIN TIME, AND ANTI-XA ACTIVITY
Pruvot S.	-	RESISTANCE TO OAC ASSOCIATED TO A NEW POINT MUTATION IN VKORC1 GENE
Pryzdial E.L.G.	-	A COMPARISON OF THE MEMBRANE BINDING PROPERTIES OF THE GAMMA-CARBOXY GLUTAMIC ACID PROTEINS OF BLOOD COAGULATION
	-	HOMOZYGOUS FACTOR V DEFICIENCY WITH MILD CLINICAL PHENOTYPE
	-	PROTEOLYTIC CONVERSION OF CLOTTING FACTOR XA INTO A FIBRINOLYSIS ACCELERATOR
Przyklenk K.	-	TARGETED INHIBITION OF THE SEROTONIN 5-HT2A RECEPTOR ATTENUATES RECURRENT PLATELET-MEDIATED THROMBOSIS IN AN IN VIVO MODEL MIMICKING UNSTABLE ANGINA
	-	QUANTITATIVE ASSESSMENT OF FIBRIN ARCHITECTURE: NOVEL TECHNIQUES AND STAINING METHODS
	-	LONG-TERM WARFARIN THERAPY IS ASSOCIATED WITH TISSUE CALCIFICATION: INFLUENCE OF TREATMENT DURATION, AGE, AND GENDER
Psaty B.M.	-	ESTROGEN USE, VARIANTS IN 24 CLOTTING GENES AND THE RISK OF THROMBOSIS IN POSTMENOPAUSAL WOMEN
	-	ASSOCIATION OF BLOOD PRESSURE AND FACTOR VIII IN LEIDEN THROMBOPHILIA STUDY (LETS) AND CARDIOVASCULAR HEALTH STUDY (CHS)
Pshenichnikova T.B.	-	INHERITED AND ACQUIRED THROMBOPHILIA IN PATIENTS WITH METABOLIC SYNDROME IN OBSTETRIC-GYNECOLOGIC PRACTICE
Puccetti L.	-	INFLUENCE OF LECTIN-LIKE OX-LDL RECEPTOR-1 (LOX-1) AND NITRIC OXIDE SINTHASE (NOS) POLYMORPHISMS IN ATORVASTATIN ANTITHROMBOTIC ACTION AND CARDIOVASCULAR EVENTS RATE
Pucci N.	-	EFFECT OF REHABILITATION PROGRAM ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS UNDERGOING CARDIAC SURGERY
	-	ROLE OF D-DIMER IN COMBINATION WITH F1+2, RVO AND THROMBOPHILIA IN THE RISK OF RECURRENCE OF PATIENTS WITH A FIRST VTE EPISODE AFTER OAT WITHDRAWA
	-	PHYSICAL ACTIVITY DURING LEISURE TIME AND PRIMARY PREVENTION OF CORONARY HEART DISEASE: AN UPDATED METAANALYSIS OF COHORT STUDIES
	-	IN PERIODONTAL DISEASE THE INFLAMMATORY STATE IS ASSOCIATED WITH SUB-CLINICAL ATHEROSCLEROSIS
Puchko T.K.	-	RECOMBINANT COAGULATION FACTOR VIIA IN THERAPY OF MASSIVE POST-PARTUM BLEEDING AT PATIENT WITH IDIOPATHIC THROMBOCYTOPENIA (ITP)
Pucinelli F.M.	-	EVIDENCE OF ASPIRIN EXCRETION FROM PLATELET BY MRP4 TRANSPORT RESPONSIBLE FOR REDUCED DRUG ACTIVITY IN PATIENTS AT 5 DAYS CABS
Pudens C.	-	INFLUENCE OF ANTIEPILEPTIC DRUGS ON THE COAGULATION
Pudil R.	-	ACETYLSALICYLIC ACID (ASA) RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE (IHD) AS BIOINDICATOR OF THE TREATMENT STRATEGY
Puehringer H.	-	REVERSE-HYBRIDIZATION-BASED GENETIC TESTING FOR THE PREDICTION OF ANTICOAGULANT DOSE REQUIREMENT
Puetz J.	-	FIRST INTERIM ANALYSIS OF SEVEN BLEEP REGISTRY FOCUSED ON EFFICACY AND SAFETY OF THE TREATMENT WITH RFVIIA IN MASSIVE HAEMORRHAGE IN CHILDREN
Pugh N.	-	INVESTIGATION OF PLATELET BINDING TO COLLAGEN PEPTIDES UNDER FLOW CONDITIONS
Pugsley M.K.	-	DESMOTEPLASE-MEDIATED PLASMINOGEN ACTIVATION AND CLOT LYSIS ARE ANTAGONIZED BY THE LYSINE ANALOGUE TRANEXAMIC ACID
Pujol N.	-	GENETIC DETERMINANTS OF PLATELET-PLATELET AND PLATELET-LEUKOCYTE AGGREGATES. RESULTS FROM THE GAIT PROJECT
Pujol-Moix N.	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Pulcinelli F.M.	-	INFLUENCE OF PLATELET GP6 HAPLOTYPES (GP6A AND GP6B)
	-	CAMP-INDUCED INHIBITION OF CA2+ MOBILIZATION IS REVERSED BY TYROSINE PHOSPHORYLATION OF IP3R IN PLATELETS
	-	PERSISTENT TXA2 PRODUCTION IN PATIENTS CHRONICALLY TREATED WITH ASPIRIN: RESIDUAL COX-1 ACTIVITY OR COX-2 ACTIVATION?
Pullens L.	-	ANAMNESIS IN PATIENTS WITH HEMOPHILIA AND INHIBITORS WHO RECEIVE ACTIVATED PROTHROMBIN COMPLEX CONCENTRATES FOR PROPHYLAXIS
Pulli R.	-	ABDOMINAL AORTIC ANEURYSM AND CAROTID ARTERY DISEASE: GENE EXPRESSION PROFILING OF TWO ATHEROSCLEROTIC DISEASES
	-	GENETIC ANALYSIS OF 56 POLYMORPHISMS IN 18 GENES INVOLVED IN HOMOCYSTEINE METABOLISM IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM
Pumfrey L.	-	THE ROLE OF FC-GAMMA RECEPTOR GENE POLYMORPHISMS IN THE CLINICAL OUTCOME OF NEWLY DIAGNOSED ITP IN CHILDREN
Puntumetakul M.	-	FIBRINOGEN THR312ALA BUT NOT FXIIIA VAL34LEU AND FXIIIB HIS95ARG POLYMORPHISMS ASSOCIATED WITH THAI DEEP VENOUS THROMBOSIS
Pureza V.S.	-	BLOOD COAGULATION REACTIONS ON NANOSCALE MEMBRANE SURFACES
Purtscher M.	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF A RVWF DRUG CANDIDATE PRODUCED UNDER SERUM-FREE CONDITIONS
Pusateri A.E.	-	CHANGES IN THROMBIN GENERATION KINETICS FOLLOWING HEMORRHAGIC SHOCK AND RESUSCITATION IN PIGS
	-	APPLICABILITY OF A THROMBIN GENERATION TEST IN LABORATORY SCREENING
Pyle M.	-	THE ALPHA FIBRINOGEN THR312ALA POLYMORPHISM AND VENOUS THROMBOEMBOLISM IN AMERICAN CAUCASIANS AND AFRICAN AMERICANS: THE GATE STUDY
Pyle M.E.	-	POLYMORPHISMS IN THE 3'-END OF THE FIBRINOGEN GAMMA GENE AND RISK OF VENOUS THROMBOEMBOLISM IN THE AFRICAN-AMERICAN AND CAUCASIAN POPULATION

| ISTH 2009